Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)


			☒						QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2024


			☐						TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________________ to ________________

Commission file number 001-41459

SILGAN HOLDINGS INC.

(Exact name of Registrant as specified in its charter)


Delaware		06-1269834
(State or other jurisdiction		(I.R.S. Employer
of incorporation or organization)		Identification No.)

4 Landmark Square
Stamford,	Connecticut	06901
(Address of principal executive offices)		(Zip Code)

(203) 975-7110

(Registrant's telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	SLGN	New York Stock Exchange

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☒

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of October 31, 2024, the number of shares outstanding of the Registrant’s common stock was 106,794,650.

-1-


SILGAN HOLDINGS INC.

TABLE OF CONTENTS

			Page No.


Part I. Financial Information			3

Item 1. Financial Statements			3

Condensed Consolidated Balance Sheets at September 30, 2024 and 2023 and December 31, 2023			3

Condensed Consolidated Statements of Income for the three and nine months ended September 30, 2024 and 2023			4

Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2024 and 2023			5

Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2024 and 2023			6

Condensed Consolidated Statements of Stockholders’ Equity for the three and nine months ended September 30, 2024 and 2023			7

Notes to Condensed Consolidated Financial Statements			8

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations			19

Item 3. Quantitative and Qualitative Disclosures About Market Risk			30

Item 4. Controls and Procedures			30

Part II. Other Information			31

Item 5. Other Information			31

Item 6. Exhibits			31

Signatures			32

-2-

Part I. Financial Information

Item 1. Financial Statements

SILGAN HOLDINGS INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in thousands)


	Sept. 30, 2024		Sept. 30, 2023		Dec. 31, 2023
	(unaudited)		(unaudited)
Assets
Current assets:
Cash and cash equivalents	$	368,507	$	307,124	$	642,923
Trade accounts receivable, net	1,210,331		1,295,882		599,524
Inventories	780,443		919,013		940,808
Prepaid expenses and other current assets	160,207		139,803		165,727
Total current assets	2,519,488		2,661,822		2,348,982

Property, plant and equipment, net	1,956,004		1,911,638		1,961,585
Goodwill	2,024,055		1,979,693		2,018,241
Other intangible assets, net	681,454		724,340		721,023
Other assets, net	566,365		534,814		561,405
	$	7,747,366	$	7,812,307	$	7,611,236

Liabilities and Stockholders’ Equity
Current liabilities:
Revolving loans and current portion of long-term debt	$	1,254,391	$	897,809	$	880,315
Trade accounts payable	678,518		651,991		1,075,913
Accrued payroll and related costs	106,367		96,375		97,886
Accrued liabilities	266,486		269,386		257,742
Total current liabilities	2,305,762		1,915,561		2,311,856

Long-term debt	2,553,659		3,312,685		2,546,451
Deferred income taxes	420,921		380,250		433,666
Other liabilities	413,054		421,922		429,905

Stockholders’ equity:
Common stock	1,751		1,751		1,751
Paid-in capital	364,074		349,634		353,848
Retained earnings	3,378,093		3,163,161		3,208,237
Accumulated other comprehensive loss	(260,597)		(309,586)		(251,361)
Treasury stock	(1,429,351)		(1,423,071)		(1,423,117)
Total stockholders’ equity	2,053,970		1,781,889		1,889,358
	$	7,747,366	$	7,812,307	$	7,611,236

See accompanying notes.

-3-

SILGAN HOLDINGS INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

For the three and nine months ended September 30, 2024 and 2023

(Dollars and shares in thousands, except per share amounts)

(Unaudited)


	Three Months Ended				Nine Months Ended
	Sept. 30, 2024		Sept. 30, 2023		Sept. 30, 2024		Sept. 30, 2023


Net sales	$	1,745,124	$	1,803,101	$	4,443,527	$	4,648,109
Cost of goods sold	1,451,831		1,517,183		3,670,751		3,874,100
Gross profit	293,293		285,918		772,776		774,009
Selling, general and administrative expenses	106,405		84,320		314,582		287,821
Rationalization charges	19,483		6,424		38,033		13,212
Other pension and postretirement expense (income)	118		1,083		(698)		3,664
Income before interest and income taxes	167,287		194,091		420,859		469,312


Interest and other debt expense	41,871		47,264		121,861		130,822
Income before income taxes	125,416		146,827		298,998		338,490
Provision for income taxes	25,363		36,210		67,684		76,954
Net income	$	100,053	$	110,617	$	231,314	$	261,536

Earnings per share:
Basic net income per share	$	0.94	$	1.02	$	2.17	$	2.39
Diluted net income per share	$	0.93	$	1.02	$	2.16	$	2.38

Weighted average number of shares:
Basic	106,847		108,421		106,776		109,583
Effect of dilutive securities	290		331		292		428
Diluted	107,137		108,752		107,068		110,011

See accompanying notes.

-4-

SILGAN HOLDINGS INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

For the three and nine months ended September 30, 2024 and 2023

(Dollars in thousands)

(Unaudited)


	Three Months Ended				Nine Months Ended
	Sept. 30, 2024		Sept. 30, 2023		Sept. 30, 2024		Sept. 30, 2023


Net income	$	100,053	$	110,617	$	231,314	$	261,536
Other comprehensive income (loss), net of tax:
Changes in net prior service credit and actuarial losses	1,719		1,995		4,533		5,518
Change in fair value of derivatives	(3,767)		1,865		(815)		5,230
Foreign currency translation	38,981		(33,892)		(12,954)		24,976
Other comprehensive income (loss)	36,933		(30,032)		(9,236)		35,724
Comprehensive income	$	136,986	$	80,585	$	222,078	$	297,260

See accompanying notes.

-5-

SILGAN HOLDINGS INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the nine months ended September 30, 2024 and 2023

(Dollars in thousands)

(Unaudited)


	2024		2023
Cash flows provided by (used in) operating activities:
Net income	$	231,314	$	261,536
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	198,648		196,722
Amortization of debt discount and debt issuance costs	4,043		4,025
Rationalization charges	38,033		13,212
Stock compensation expense	11,727		11,348

Other changes that provided (used) cash:
Trade accounts receivable, net	(614,632)		(638,282)
Inventories	160,756		(152,891)
Trade accounts payable	(213,088)		(233,724)
Accrued liabilities	(6,978)		(31,055)

Other, net	(23,711)		(26,933)
Net cash (used in) operating activities	(213,888)		(596,042)

Cash flows provided by (used in) investing activities:

Capital expenditures	(192,035)		(173,453)
Proceeds from asset sales	3,221		1,628
Other, net	(293)		1,267
Net cash (used in) investing activities	(189,107)		(170,558)

Cash flows provided by (used in) financing activities:
Borrowings under revolving loans	802,389		1,119,960
Repayments under revolving loans	(310,827)		(281,067)
Repayment of principal amounts under finance leases	(27,281)		(2,208)
Proceeds from issuance of long-term debt	—		8,649
Repayments of long-term debt	(100,000)		(52,650)
Changes in outstanding checks - principally vendors	(160,576)		(61,433)
Dividends paid on common stock	(61,754)		(59,712)


Repurchase of common stock	(7,735)		(183,939)


Net cash provided by financing activities	134,216		487,600

Effect of exchange rate changes on cash and cash equivalents	(5,637)		502

Cash and cash equivalents:
Net (decrease)	(274,416)		(278,498)
Balance at beginning of year	642,923		585,622
Balance at end of period	$	368,507	$	307,124

Interest paid, net	$	133,411	$	123,944
Income taxes paid, net	69,748		95,911

See accompanying notes.

-6-

SILGAN HOLDINGS INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

For the three and nine months ended September 30, 2024 and 2023

(Dollars and shares in thousands, except per share amounts)

(Unaudited)


	Three Months Ended				Nine Months Ended
	Sept. 30, 2024		Sept. 30, 2023		Sept. 30, 2024		Sept. 30, 2023


Common stock - shares outstanding
Balance at beginning of period	106,779		109,946		106,500		110,079
Net issuance of treasury stock for vested restricted stock units	16		—		295		312
Repurchases of common stock	—		(3,448)		—		(3,893)
Balance at end of period	106,795		106,498		106,795		106,498

Common stock - par value
Balance at beginning and end of period	$	1,751	$	1,751	$	1,751	$	1,751

Paid-in capital
Balance at beginning of period	360,344		345,442		353,848		339,839
Stock compensation expense	3,779		4,192		11,727		11,348
Net issuance of treasury stock for vested restricted stock units	(49)		—		(1,501)		(1,553)
Balance at end of period	364,074		349,634		364,074		349,634

Retained earnings
Balance at beginning of period	3,298,525		3,072,021		3,208,237		2,961,079
Net income	100,053		110,617		231,314		261,536
Dividends declared on common stock	(20,485)		(19,477)		(61,458)		(59,454)
Balance at end of period	3,378,093		3,163,161		3,378,093		3,163,161

Accumulated other comprehensive loss
Balance at beginning of period	(297,530)		(279,554)		(251,361)		(345,310)
Other comprehensive income (loss)	36,933		(30,032)		(9,236)		35,724
Balance at end of period	(260,597)		(309,586)		(260,597)		(309,586)

Treasury stock
Balance at beginning of period	(1,429,400)		(1,268,524)		(1,423,117)		(1,239,103)
Net issuance of treasury stock for vested restricted stock units	49		—		(6,234)		(7,664)
Repurchases of common stock	—		(154,547)		—		(176,304)
Balance at end of period	(1,429,351)		(1,423,071)		(1,429,351)		(1,423,071)
Total stockholders’ equity	$	2,053,970	$	1,781,889	$	2,053,970	$	1,781,889

Dividends declared on common stock per share	$	0.19	$	0.18	$	0.57	$	0.54

See accompanying notes.

-7-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at September 30, 2024 and 2023 and for the

three and nine months then ended is unaudited)

Note 1. Significant Accounting Policies

Basis of Presentation. The accompanying unaudited condensed consolidated financial statements of Silgan Holdings Inc., or Silgan, have been prepared in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the accompanying financial statements include all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation. The results of operations for any interim period are not necessarily indicative of the results of operations for the full year.

The Condensed Consolidated Balance Sheet at December 31, 2023 has been derived from our audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.

You should read the accompanying condensed consolidated financial statements in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2023.

Certain prior year amounts have been reclassified to conform with the current year's presentation.

Goodwill and Other Intangible Assets. We review goodwill and other indefinite-lived intangible assets for impairment as of July 1 of each year and more frequently if circumstances indicate a possible impairment. We determined that our goodwill and other indefinite-lived intangible assets were not impaired in our annual 2024 assessment performed during the third quarter.

Note 2. Revenue

The following tables present our revenues disaggregated by reportable segment and geography as they best depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. Revenues by segment were as follows:


	Three Months Ended				Nine Months Ended
	Sept. 30, 2024		Sept. 30, 2023		Sept. 30, 2024		Sept. 30, 2023

	(Dollars in thousands)
Dispensing and Specialty Closures	$	563,669	$	559,081	$	1,664,966	$	1,699,109
Metal Containers	1,022,605		1,094,609		2,290,530		2,475,569
Custom Containers	158,850		149,411		488,031		473,431
	$	1,745,124	$	1,803,101	$	4,443,527	$	4,648,109

Revenues by geography were as follows:


	Three Months Ended				Nine Months Ended
	Sept. 30, 2024		Sept. 30, 2023		Sept. 30, 2024		Sept. 30, 2023

	(Dollars in thousands)
North America	$	1,368,104	$	1,437,539	$	3,384,468	$	3,555,971
Europe and other	377,020		365,562		1,059,059		1,092,138
	$	1,745,124	$	1,803,101	$	4,443,527	$	4,648,109

Our contract assets primarily consist of unbilled accounts receivable related to over time revenue recognition and were $110.7 million, $104.2 million, and $100.0 million as of September 30, 2024 and 2023 and December 31, 2023, respectively. Unbilled receivables are included in trade accounts receivable, net on our Condensed Consolidated Balance Sheets.

-8-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at September 30, 2024 and 2023 and for the

three and nine months then ended is unaudited)

Note 3. Rationalization Charges


	Three Months Ended				Nine Months Ended
	Sept. 30, 2024		Sept. 30, 2023		Sept. 30, 2024		Sept. 30, 2023

	(Dollars in thousands)
Dispensing and Specialty Closures	$	9,835	$	3,836	$	19,583	$	5,164
Metal Containers	7,850		2,588		13,927		7,944
Custom Containers	1,798		—		4,523		104
	$	19,483	$	6,424	$	38,033	$	13,212

Activity in reserves for our rationalization plans were as follows:


	Employee Severance and Benefits		Plant Exit Costs		Non-Cash Asset Write-Downs		Total
	(Dollars in thousands)
Balance at December 31, 2023	$	33,555	$	465	$	—	$	34,020
Charged to expense	6,723		19,942		11,368		38,033
Utilized and currency translation	(10,842)		(20,407)		(11,368)		(42,617)
Balance at September 30, 2024	$	29,436	$	—	$	—	$	29,436

Non-cash asset write-downs were the result of comparing the carrying value of certain facilities and production related equipment to their fair value using estimated future discounted cash flows, a Level 3 fair value measurement (see Note 7 for information regarding a Level 3 fair value measurement).

Rationalization reserves as of September 30, 2024 were recorded in our Condensed Consolidated Balance Sheet as accrued liabilities of $3.6 million and other liabilities of $25.8 million. Excluding the impact of our withdrawal from the Central States, Southeast and Southwest Areas Pension Plan, or the Central States Pension Plan, in 2019, remaining expenses and cash expenditures for our rationalization plans are expected to be $6.9 million and $9.5 million, respectively. Remaining expenses for the accretion of interest for the withdrawal liability related to the Central States Pension Plan are expected to average approximately $0.8 million per year and be recognized annually through 2040, and remaining cash expenditures for the withdrawal liability related to the Central States Pension Plan are expected to be approximately $2.6 million annually through 2040.

-9-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at September 30, 2024 and 2023 and for the

three and nine months then ended is unaudited)

Note 4. Accumulated Other Comprehensive Loss

Accumulated other comprehensive loss is reported in our Condensed Consolidated Statements of Stockholders’ Equity. Amounts included in accumulated other comprehensive loss, net of tax, were as follows:


	Unrecognized Net Defined Benefit Plan Costs		Change in Fair Value of Derivatives		Foreign Currency Translation		Total
	(Dollars in thousands)
Balance at December 31, 2023	$	(133,523)	$	(216)	$	(117,622)	$	(251,361)
Other comprehensive loss before reclassifications	—		837		(12,954)		(12,117)
Amounts reclassified from accumulated other comprehensive loss	4,533		(1,652)		—		2,881
Other comprehensive loss	4,533		(815)		(12,954)		(9,236)
Balance at September 30, 2024	$	(128,990)	$	(1,031)	$	(130,576)	$	(260,597)

The amounts reclassified to earnings from the unrecognized net defined benefit plan costs component of accumulated other comprehensive loss for the three and nine months ended September 30, 2024 were net (losses) of $(2.2) million and $(5.7) million, respectively, excluding income tax benefits of $0.4 million and $1.2 million, respectively. For the three and nine months ended September 30, 2024, these net (losses) consisted primarily of amortization of net actuarial (losses) of $(2.1) million and $(5.7) million, respectively. Amortization of net actuarial losses and net prior service cost was recorded in other pension and postretirement income in our Condensed Consolidated Statements of Income. See Note 10 for further information.

The amounts reclassified to earnings from the change in fair value of derivatives component of accumulated other comprehensive loss for the three and nine months ended September 30, 2024 were not significant.

Other comprehensive loss before reclassifications related to foreign currency translation for the three and nine months ended September 30, 2024 consisted of (i) foreign currency gains (losses) related to translation of quarter end financial statements of foreign subsidiaries utilizing a functional currency other than the U.S. dollar of $54.8 million and $(8.9) million, respectively, and (ii) foreign currency (losses) related to our net investment hedges of $(20.9) million and $(5.4) million, respectively, excluding income tax benefits of $5.0 million and $1.3 million, respectively. See Note 7 for further discussion.

-10-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at September 30, 2024 and 2023 and for the

three and nine months then ended is unaudited)

Note 5. Inventories

Inventories consisted of the following:


	Sept. 30, 2024		Sept. 30, 2023		Dec. 31, 2023
	(Dollars in thousands)
Raw materials	$	400,916	$	460,137	$	465,375
Work-in-process	192,986		220,164		219,462
Finished goods	486,641		565,790		556,737
Other	17,282		17,234		16,616
	1,097,825		1,263,325		1,258,190
Adjustment to value inventory at cost on the LIFO method	(317,382)		(344,312)		(317,382)
	$	780,443	$	919,013	$	940,808

Note 6. Long-Term Debt

Long-term debt consisted of the following:


	Sept. 30, 2024		Sept. 30, 2023		Dec. 31, 2023
	(Dollars in thousands)
Bank debt
Bank revolving loans	$	505,000	$	818,000	$	—
U.S. term loans	850,000		950,000		950,000

Other foreign bank revolving and term loans	43,127		75,502		56,243
Total bank debt	1,398,127		1,843,502		1,006,243



3¼% Senior Notes	725,400		688,155		717,990
4⅛% Senior Notes	600,000		600,000		600,000
2¼% Senior Notes	558,000		529,350		552,300
1.4% Senior Secured Notes	500,000		500,000		500,000
Finance leases	36,342		63,663		63,302
Total debt - principal	3,817,869		4,224,670		3,439,835
Less unamortized debt issuance costs and debt discount	9,819		14,176		13,069
Total debt	3,808,050		4,210,494		3,426,766
Less current portion	1,254,391		897,809		880,315
	$	2,553,659	$	3,312,685	$	2,546,451

At September 30, 2024, the current portion of long-term debt consisted of $725.4 million of 3¼% Senior Notes due 2025, or the 3¼% Senior Notes, $505.0 million of U.S. revolving loans under our amended and restated senior secured credit facility, as amended, or the Credit Agreement, $22.3 million of other foreign bank revolving and term loans and $1.7 million of finance leases. See Note 15 for further information.

-11-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at September 30, 2024 and 2023 and for the

three and nine months then ended is unaudited)

Note 7. Financial Instruments

The financial instruments recorded in our Condensed Consolidated Balance Sheets include cash and cash equivalents, trade accounts receivable, trade accounts payable, debt obligations and swap agreements. Due to their short-term maturity, the carrying amounts of trade accounts receivable and trade accounts payable approximate their fair market values. The following table summarizes the carrying amounts and estimated fair values of our other financial instruments at September 30, 2024:


	Carrying Amount		Fair Value
	(Dollars in thousands)
Assets:
Cash and cash equivalents	$	368,507	$	368,507


Liabilities:
Bank debt	$	1,398,127	$	1,398,127


3¼% Senior Notes	725,400		723,949
4⅛% Senior Notes	599,532		585,354
2¼% Senior Notes	558,000		524,609
1.4% Senior Secured Notes	499,916		474,235

Fair Value Measurements

GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). GAAP classifies the inputs used to measure fair value into a hierarchy consisting of three levels. Level 1 inputs represent unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 inputs represent unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability. Level 3 inputs represent unobservable inputs for the asset or liability. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

Financial Instruments Measured at Fair Value

The financial assets and liabilities that were measured on a recurring basis at September 30, 2024 consisted of our cash and cash equivalents and derivative instruments. We measured the fair value of cash and cash equivalents using Level 1 inputs. We measured the fair value of our derivative instruments using the income approach. The fair value of our derivative instruments reflects the estimated amounts that we would pay or receive based on the present value of the expected cash flows derived from market interest rates and prices. As such, these derivative instruments were classified within Level 2.

Financial Instruments Not Measured at Fair Value

Our bank debt, 3¼% Senior Notes, 4⅛% Senior Notes, 2¼% Senior Notes and 1.4% Senior Secured Notes were recorded at historical amounts in our Condensed Consolidated Balance Sheets, as we have not elected to measure them at fair value. We measured the fair value of our variable rate bank debt using the market approach based on Level 2 inputs. Fair values of the 3¼% Senior Notes, 4⅛% Senior Notes, 2¼% Senior Notes and 1.4% Senior Secured Notes were estimated based on quoted market prices, a Level 1 input.

Derivative Instruments and Hedging Activities

Our derivative financial instruments were recorded in the Condensed Consolidated Balance Sheets at their fair values. Changes in fair values of derivatives are recorded in each period in earnings or comprehensive income, depending on whether a derivative is designated as part of a hedge transaction and, if it is, the type of hedge transaction.

-12-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at September 30, 2024 and 2023 and for the

three and nine months then ended is unaudited)

We utilize certain derivative financial instruments to manage a portion of our interest rate and natural gas cost exposures. We generally limit our use of derivative financial instruments to interest rate and natural gas swap agreements. We do not engage in trading or other speculative uses of these financial instruments. For a financial instrument to qualify as a hedge, we must be exposed to interest rate or price risk, and the financial instrument must reduce the exposure and be designated as a hedge. Financial instruments qualifying for hedge accounting must maintain a high correlation between the hedging instrument and the item being hedged, both at inception and throughout the hedged period.

We also utilize certain internal hedging strategies to minimize our foreign currency exchange rate risk. Net investment hedges that qualify for hedge accounting result in the recognition of foreign currency gains or losses, net of tax, in accumulated other comprehensive loss.

Interest Rate Swap Agreements

In March 2023, we entered into $300 million aggregate notional principal amount of U.S. dollar interest rate swap agreements to manage a portion of our exposure to interest rate fluctuations. These agreements have a weighted average fixed rate of 3.90 percent, mature in April 2026 and were entered into with financial institutions which are expected to fully perform under the terms thereof. The difference between amounts to be paid or received on our interest rate swap agreements is recorded in interest and other debt expense in our Condensed Consolidated Statements of Income and was not significant for the three and nine months ended September 30, 2024. The total fair value of our interest rate swaps agreements in effect at September 30, 2024 was not significant. See Note 15 for further information.

Natural Gas Swap Agreements

We have entered into natural gas swap agreements to manage a portion of our exposure to fluctuations in natural gas prices. The difference between amounts to be paid or received on our natural gas swap agreements is recorded in cost of goods sold in our Condensed Consolidated Statements of Income and was not significant for the three and nine months ended September 30, 2024. These agreements are with a financial institution which is expected to fully perform under the terms thereof. The total fair value of our natural gas swap agreements in effect at September 30, 2024 was not significant.

Foreign Currency Exchange Rate Risk

In an effort to minimize our foreign currency exchange rate risk, we have financed acquisitions of foreign operations primarily with borrowings denominated in Euros. In addition, where available, we have borrowed funds in local currency or implemented certain internal hedging strategies to minimize our foreign currency exchange rate risk related to foreign operations, including net investment hedges related to the 3¼% Senior Notes which are Euro denominated. Foreign currency (losses) related to our net investment hedges included in accumulated other comprehensive loss for the three and nine months ended September 30, 2024 were $(20.9) million and $(5.4) million, respectively.

-13-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at September 30, 2024 and 2023 and for the

three and nine months then ended is unaudited)

Note 8. Commitments and Contingencies

We are a party to other legal proceedings, contract disputes and claims arising in the ordinary course of our business. We are not a party to, and none of our properties are subject to, any pending legal proceedings which could have a material adverse effect on our business or financial condition.

Note 9. Supply Chain Finance Program

We have a supply chain finance (“SCF”) program with a major global financial institution. Under this SCF program, a qualifying supplier may elect, but is not obligated, to sell its receivables from us to such financial institution. Once a qualifying supplier elects to participate in this SCF program, all of our payments to the participating supplier are paid to such financial institution in this SCF program on the invoice due date under our agreement with such supplier, regardless of whether the individual invoice was sold by the supplier to such financial institution. We may terminate our agreement with the financial institution upon at least 30 days’ notice, and the financial institution may terminate our agreement upon at least 10 days’ notice. Additionally, suppliers who elect to participate in this SCF program may terminate their participation upon at least 30 days’ notice. The suppliers' invoices sold under this SCF program can be outstanding up to 210 days from the invoice date. Suppliers’ invoices included in this SCF program were $284.2 million, $294.1 million and $330.2 million at September 30, 2024 and 2023 and December 31, 2023, respectively, and were included in accounts payable in our Condensed Consolidated Balance Sheets.

Note 10. Retirement Benefits

The components of the net periodic pension benefit cost were as follows:


	Three Months Ended				Nine Months Ended
	Sept. 30, 2024		Sept. 30, 2023		Sept. 30, 2024		Sept. 30, 2023

	(Dollars in thousands)
Service cost	$	1,990	$	1,962	$	6,319	$	6,425
Interest cost	8,592		8,617		25,413		26,050
Expected return on plan assets	(10,772)		(10,211)		(32,314)		(30,587)
Amortization of prior service cost	22		29		68		82
Amortization of actuarial losses	2,232		2,845		5,937		8,729

Net periodic benefit cost	$	2,064	$	3,242	$	5,423	$	10,699

The components of the net periodic other postretirement benefit cost (credit) were as follows:


	Three Months Ended				Nine Months Ended
	Sept. 30, 2024		Sept. 30, 2023		Sept. 30, 2024		Sept. 30, 2023

	(Dollars in thousands)
Service cost	$	8	$	12	$	22	$	38
Interest cost	151		181		483		559
Amortization of prior service credit	(5)		(237)		(15)		(705)
Amortization of actuarial gains	(102)		(141)		(270)		(464)
Net periodic benefit cost (credit)	$	52	$	(185)	$	220	$	(572)

-14-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at September 30, 2024 and 2023 and for the

three and nine months then ended is unaudited)

Note 11. Income Taxes

Silgan and its subsidiaries file U.S. Federal income tax returns, as well as income tax returns in various states and foreign jurisdictions. The Internal Revenue Service, or IRS, has completed its review of the 2022 tax year with no change to our filed federal income tax return. We have been accepted into the Compliance Assurance Program for the 2023 and 2024 tax years which provides for the review by the IRS of tax matters relating to our tax return prior to filing.

Note 12. Treasury Stock

On March 4, 2022, our Board of Directors authorized the repurchase by us of up to an aggregate of $300.0 million of our common stock by various means from time to time through and including December 31, 2026. We did not repurchase any shares of our common stock pursuant to this authorization during the nine months ended September 30, 2024. At September 30, 2024, we had approximately $93.3 million remaining under this authorization for the repurchase of our common stock.

During the first nine months of 2024, we issued 470,788 treasury shares which had an average cost of $3.19 per share for restricted stock units that vested during the period that had been previously issued under our stock-based compensation plans. In accordance with the applicable agreements for such restricted stock units, we repurchased 176,093 shares of our common stock at an average cost of $43.92 to satisfy minimum employee withholding tax requirements resulting from the vesting of such restricted stock units.

We account for treasury shares using the first-in, first-out (FIFO) cost method. As of September 30, 2024, 68,317,846 shares of our common stock were held in treasury.

Note 13. Stock-Based Compensation

We currently have one stock-based compensation plan in effect under which we have issued restricted stock units to our officers, other key employees and outside directors. During the first nine months of 2024, 490,672 restricted stock units were granted to certain of our officers, other key employees and outside directors. The fair value of these restricted stock units at the grant date was $21.6 million, which is being amortized ratably over the respective vesting period from the grant date.

-15-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at September 30, 2024 and 2023 and for the

three and nine months then ended is unaudited)

Note 14. Segment Information

We evaluate performance of our business segments and allocate resources based on the adjusted EBIT of our business segments. Adjusted EBIT is not a defined term under GAAP. We define adjusted EBIT as income before interest and income taxes excluding acquired intangible asset amortization expense, other pension (income) expense for U.S. pension plans, rationalization charges and costs attributed to announced acquisitions. Adjusted EBIT should not be considered in isolation or as a substitute for income before interest and income taxes or any other financial data prepared in accordance with GAAP and may not be comparable to calculations of similarly titled measures by other companies.

Reportable segment information was as follows:


	Dispensing and Specialty Closures		Metal Containers		Custom Containers		Corporate		Total
	(Dollars in thousands)
Three Months Ended September 30, 2024
Net sales	$	563,669	$	1,022,605	$	158,850	$	—	$	1,745,124
Income before interest and income taxes	74,659		89,307		17,136		(13,815)		167,287
Adjusted EBIT	95,216		97,065		20,011		(6,704)		205,588
Depreciation	25,755		19,801		8,747		47		54,350

Three Months Ended September 30, 2023
Net sales	$	559,081	$	1,094,609	$	149,411	$	—	$	1,803,101
Income before interest and income taxes	77,949		110,185		10,668		(4,711)		194,091
Adjusted EBIT	93,786		113,519		11,839		(4,711)		214,433
Depreciation	25,691		18,177		8,089		8		51,965

Nine Months Ended September 30, 2024
Net sales	$	1,664,966	$	2,290,530	$	488,031	$	—	$	4,443,527
Income before interest and income taxes	213,320		187,290		55,464		(35,215)		420,859
Adjusted EBIT	265,773		200,532		62,724		(22,597)		506,432
Depreciation	76,290		57,606		26,634		115		160,645

Nine Months Ended September 30, 2023
Net sales	$	1,699,109	$	2,475,569	$	473,431	$	—	$	4,648,109
Income before interest and income taxes	212,612		231,563		46,082		(20,945)		469,312
Adjusted EBIT	253,604		241,659		50,317		(20,945)		524,635
Depreciation	76,206		54,693		25,923		66		156,888

-16-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at September 30, 2024 and 2023 and for the

three and nine months then ended is unaudited)

Total adjusted EBIT is reconciled to income before income taxes as follows:


	Three Months Ended				Nine Months Ended
	Sept. 30, 2024		Sept. 30, 2023		Sept. 30, 2024		Sept. 30, 2023

	(Dollars in thousands)
Total adjusted EBIT	$	205,588	$	214,433	$	506,432	$	524,635
Less:
Acquired intangible asset amortization expense	12,367		13,309		38,004		39,834
Other pension (income) expense for U.S. pension plans	(660)		609		(3,082)		2,277
Rationalization charges	19,483		6,424		38,033		13,212
Costs attributed to announced acquisitions	7,111		—		12,618		—

Income before interest and income taxes	167,287		194,091		420,859		469,312
Less interest and other debt expense	41,871		47,264		121,861		130,822
Income before income taxes	$	125,416	$	146,827	$	298,998	$	338,490

Net sales and adjusted EBIT of our metal containers segment and of part of our dispensing and specialty closures segment are dependent, in part, upon the vegetable and fruit harvests in the United States and, to a lesser extent, in a variety of national growing regions in Europe. The size and quality of these harvests varies from year to year, depending in large part upon the weather conditions in applicable regions. Because of the seasonality of the harvests, we have historically experienced higher unit sales volume in the third quarter of our fiscal year and generated a disproportionate amount of our annual adjusted EBIT during that quarter.

Note 15. Subsequent Events

Weener Plastics Holding B.V. Acquisition

On October 15, 2024, we acquired Weener Plastics Holding B.V., or Weener, a leading producer of differentiated dispensing solutions for personal care, food and healthcare products. Weener operates a global network of 19 facilities predominantly in Europe and the Americas, with approximately 4,000 employees and proprietary manufacturing technologies including significant clean room capabilities. The purchase price for this acquisition of approximately €844.2 million, net of cash acquired, was funded with term and revolving loan borrowings under the Credit Agreement, including a new €700.0 million incremental term loan, and cash on hand.

Euro Interest Rate Swap Agreements

In October 2024, we entered into €685.0 million aggregate notional principal amount of Euro interest rate swap agreements to manage a portion of our exposure to interest rate fluctuations for our Euro term loans under the Credit Agreement, which mature as follows: €35.0 million in October 2026, €70.0 million in October 2027 and €580.0 million in October 2030. These agreements have a weighted average fixed rate of 2.43 percent and were entered into with financial institutions which are expected to fully perform under the terms thereof.

Amendment to Bank Credit Agreement

On November 4, 2024, we and certain of our wholly owned subsidiaries amended the Credit Agreement by entering into a Fifth Amendment to Amended and Restated Credit Agreement (the “Fifth Amendment”) with the Lenders therein and Wells Fargo Bank, National Association, as Administrative Agent. The Fifth Amendment:

•refinanced outstanding term loans and revolving loans thereunder and extended the maturity dates to (i) November 4, 2029 with respect to revolving loans and (ii) November 4, 2030 with respect to term loans;

-17-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at September 30, 2024 and 2023 and for the

three and nine months then ended is unaudited)

used to fund a portion of the purchase price for Weener and to pay fees, expenses and costs associated with the Fifth Amendment.

•removed the springing maturity date provisions that would have shortened the maturity dates under the Credit Agreement to the date that is 91 days prior to the maturity dates of the 3¼% Senior Notes and 1.4% Senior Secured Notes due 2026 (unless such notes were refinanced or repaid prior thereto);

•improved the interest rate margin grid for term loans;

•increased the uncommitted multi-currency incremental loan facility from $1.25 billion to $1.5 billion;

•amended certain covenants to provide additional flexibility; and

•amended certain other terms of the Credit Agreement.

Pursuant to the Fifth Amendment, U.S. term loans are repayable in installments as follows: $8.5 million on December 31, 2025, $42.5 million on December 31, 2026, $85.0 million on each of December 31, 2027, 2028 and 2029 and $544.0 million on November 4, 2030, and Euro term loans are repayable in installments as follows: €9.0 million on December 31, 2025, €45.0 million on December 31, 2026, €90.0 million on each of December 31, 2027, 2028 and 2029 and €576.0 million on November 4, 2030.

-18-

Item 2.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Statements included in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this Quarterly Report on Form 10-Q that are not historical facts are “forward-looking statements” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and Securities Exchange Act of 1934, as amended. Such forward-looking statements are made based upon management’s expectations and beliefs concerning future events impacting us and therefore involve a number of uncertainties and risks, including, but not limited to, those described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and in our other filings with the Securities and Exchange Commission. As a result, the actual results of our operations or our financial condition could differ materially from those expressed or implied in these forward-looking statements.

General

We are a leading manufacturer and supplier of sustainable rigid packaging solutions for the world's essential consumer goods products. We currently produce dispensing and specialty closures for the fragrance and beauty, food, beverage, personal and health care, home care and lawn and garden markets; steel and aluminum containers for pet and human food and general line products; and custom designed plastic containers for the pet and human food, consumer health and pharmaceutical, personal care, home care, lawn and garden and automotive markets. We are a leading worldwide manufacturer of dispensing and specialty closures, a leading manufacturer of metal containers in North America and Europe, and a leading manufacturer of custom containers in North America for a variety of markets.

Our objective is to increase shareholder value by efficiently deploying capital and management resources to grow our business, reduce operating costs and build sustainable competitive positions, or franchises, and to complete acquisitions that generate attractive cash returns. We have grown our net sales and income from operations largely through acquisitions but also through internal growth, and we continue to evaluate acquisition opportunities in the consumer goods packaging market. If acquisition opportunities are not identified over a longer period of time, we may use our cash flow to repay debt, repurchase shares of our common stock or increase dividends to our stockholders or for other permitted purposes.

-19-

RESULTS OF OPERATIONS

The following table sets forth certain unaudited income statement data expressed as a percentage of net sales for the periods presented:


	Three Months Ended				Nine Months Ended
	Sept. 30, 2024		Sept. 30, 2023		Sept. 30, 2024		Sept. 30, 2023

Net sales
Dispensing and Specialty Closures	32.3	%	31.0	%	37.5	%	36.5	%
Metal Containers	58.6		60.7		51.5		53.3
Custom Containers	9.1		8.3		11.0		10.2
Consolidated	100.0		100.0		100.0		100.0
Cost of goods sold	83.2		84.1		82.6		83.3
Gross profit	16.8		15.9		17.4		16.7
Selling, general and administrative expenses	6.1		4.7		7.1		6.2
Rationalization charges	1.1		0.4		0.8		0.3
Other pension and postretirement expense (income)	—		0.1		—		0.1
Income before interest and income taxes	9.6		10.7		9.5		10.1
Interest and other debt expense	2.4		2.6		2.8		2.8
Income before income taxes	7.2		8.1		6.7		7.3
Provision for income taxes	1.5		2.0		1.5		1.7
Net income	5.7	%	6.1	%	5.2	%	5.6	%

Summary unaudited results of operations for the periods presented are provided below.


	Three Months Ended				Nine Months Ended
	Sept. 30, 2024		Sept. 30, 2023		Sept. 30, 2024		Sept. 30, 2023

	(dollars in millions)
Net sales
Dispensing and Specialty Closures	$	563.7	$	559.1	$	1,665.0	$	1,699.1
Metal Containers	1,022.6		1,094.6		2,290.5		2,475.6
Custom Containers	158.8		149.4		488.0		473.4
Consolidated	$	1,745.1	$	1,803.1	$	4,443.5	$	4,648.1

Income before interest and income taxes
Dispensing and Specialty Closures	$	74.7	$	78.0	$	213.3	$	212.6
Metal Containers	89.3		110.1		187.3		231.6
Custom Containers	17.1		10.7		55.5		46.1
Corporate	(13.8)		(4.7)		(35.2)		(21.0)
Consolidated	$	167.3	$	194.1	$	420.9	$	469.3

Net Sales. In the third quarter of 2024, consolidated net sales were $1.75 billion, a decrease of $58.0 million, or 3.2 percent, as compared to the third quarter of 2023 primarily due to the unfavorable impact from the pass through of lower raw material costs in the dispensing and specialty closures and metal containers segments, a less favorable mix of products sold in the metal containers segment and lower volumes in the dispensing and specialty closures segment. These decreases were partially offset by higher volumes in the metal containers and custom containers segments, a more favorable mix of products sold in the dispensing and specialty closures segment and the pass through of higher raw material costs in the custom containers segment.

In the first nine months of 2024, consolidated net sales were $4.4 billion, a decrease of $204.6 million, or 4.4 percent, as compared to the first nine months of 2023 primarily due to the unfavorable impact from the pass through of lower raw material

-20-

costs in the dispensing and specialty closures and metal containers segments, lower volumes in the dispensing and specialty closures segment and a less favorable mix of products sold in the metal containers and custom containers segments. These decreases were partially offset by a more favorable mix of products sold in the dispensing and specialty closures segment, higher volumes and the pass through of higher raw material costs in the custom containers segment and the impact from favorable foreign currency translation.

Gross Profit. Gross profit margin increased 0.9 percentage points to 16.8 percent in the third quarter of 2024 and increased 0.7 percentage points to 17.4 percent in the first nine months of 2024 as compared to the same periods in 2023 primarily for the reasons discussed below in "Income before Interest and Income Taxes."

Selling, General and Administrative Expenses. In the third quarter of 2024, selling, general and administrative expenses as a percentage of consolidated net sales increased to 6.1 percent as compared to 4.7 percent in the third quarter of 2023. For the third quarter of 2024, selling, general and administrative expenses increased $22.1 million to $106.4 million as compared to the third quarter of 2023. In the first nine months of 2024, selling, general and administrative expenses as a percentage of consolidated net sales increased to 7.1 percent as compared to 6.2 percent in the first nine months of 2023. In the first nine months of 2024, selling, general and administrative expenses increased $26.8 million to $314.6 million as compared to the first nine months of 2023. The increase in selling, general and administrative expenses for the third quarter and the first nine months of 2024 was primarily due to $7.1 million and $12.6 million, respectively, of costs attributed to announced acquisitions and insurance proceeds received in the prior year periods.

Income before Interest and Income Taxes. In the third quarter of 2024, income before interest and income taxes decreased by $26.8 million to $167.3 million as compared to $194.1 million in the third quarter of 2023, and margins decreased to 9.6 percent from 10.7 percent over the same periods. The decrease in income before interest and income taxes was primarily the result of higher selling, general and administrative costs, higher rationalization charges, a less favorable mix of products sold in the metal containers segment, and the unfavorable impact of foreign currency and lower volumes in the dispensing and specialty closures segment, partially offset by improved manufacturing productivity and cost performance in the dispensing and specialty closures segment, a more favorable mix of products sold in the dispensing and specialty closures and custom containers segments and higher volumes in the metal containers and custom containers segments. Rationalization charges were $19.5 million and $6.4 million in the third quarters of 2024 and 2023, respectively.

In the first nine months of 2024, income before interest and income taxes decreased by $48.4 million to $420.9 million as compared to $469.3 million in the first nine months of 2023, and margins decreased to 9.5 percent from 10.1 percent over the same periods. The decrease in income before interest and income taxes was primarily the result of the unfavorable impact of lower fixed cost absorption in the metal containers segment as a result of a significantly lower inventory build in the current year period due to a reduction in pack plans of a large fruit and vegetable customer to reduce its working capital, higher rationalization charges, higher selling, general and administrative costs, the unfavorable impact in the metal containers segment of the sale of higher cost metal inventory from the prior year due to lower metal costs in 2024 in the European operations, a less favorable mix of products sold in the metal containers segment and lower volumes in the dispensing and specialty closures segment, partially offset by improved manufacturing productivity and cost performance in the dispensing and specialty closures segment, a more favorable mix of products sold in the dispensing and specialty closures and custom containers segments and higher volumes in the custom containers segment. Rationalization charges were $38.0 million and $13.2 million in the first nine months of 2024 and 2023, respectively.

Interest and Other Debt Expense. In the third quarter of 2024, interest and other debt expense decreased $5.4 million to $41.9 million as compared to $47.3 million in the third quarter of 2023. In the first nine months of 2024, interest and other debt expense decreased $8.9 million to $121.9 million as compared to $130.8 million in the first nine months of 2023. The decrease in the third quarter of 2024 was primarily due to lower average borrowings during the current year period, partially offset by the impact of higher weighted average interest rates. The decrease in the first nine months of 2024 was primarily due to lower average borrowings during the current year period and the write-off in the prior year period of $3.5 million of accrued interest income associated with a historical acquisition tax indemnity, partially offset by the impact of higher weighted average interest rates.

Provision for Income Taxes. For the third quarters of 2024 and 2023, the effective tax rates were 20.2 percent and 24.7 percent, respectively. For the first nine months of 2024 and 2023, the effective tax rates were 22.6 percent and 22.7 percent, respectively. The effective tax rate for the third quarter of 2024 was favorably impacted by the reversal of tax reserves due to the expiration of statutes of limitation. The effective tax rate for the first nine months of 2023 was favorably impacted by the reversal of tax reserves associated with a historical acquisition indemnity which unfavorably impacted corporate and interest expense in such period.

-21-

Non-GAAP Measures

Generally accepted accounting principles in the United States are commonly referred to as GAAP. A non-GAAP financial measure is generally defined as a financial measure that purports to measure financial performance, financial position or liquidity but excludes or includes amounts that could not be so adjusted in the most comparable GAAP measure. Adjusted EBIT and adjusted EBIT margin are unaudited supplemental measures of financial performance that the Company uses, which are not required by, or presented in accordance with, GAAP and therefore are non-GAAP financial measures. These non-GAAP financial measures should not be considered as alternatives to income before interest and income taxes or any other measures derived in accordance with GAAP. Such non-GAAP financial measures should not be considered in isolation or as a substitute for any financial data prepared in accordance with GAAP and may not be comparable to similarly titled measures used by other companies. The Company uses such non-GAAP financial measures because it considers them to be important and useful supplemental measures of its and its segments’ financial performance which provide a more complete understanding of the Company and its segments than could be obtained absent such non-GAAP financial measures. The Company believes that it is important and useful to present these non-GAAP financial measures because they allow for a better period-over-period comparison of results by removing the impact of items that, in management’s view, do not reflect the Company’s or its segments’ core operating performance. Management uses these non-GAAP financial measures to review and analyze the operating performance of the Company and its segments. Investors and others are urged to review and consider carefully the adjustments made by management to the most comparable GAAP financial measure to arrive at these non-GAAP financial measures.

Adjusted EBIT, a non-GAAP financial measure, means income before interest and income taxes excluding, as applicable, acquired intangible asset amortization expense, other pension (income) expense for U.S. pension plans, rationalization charges and costs attributed to announced acquisitions. Adjusted EBIT margin, a non-GAAP financial measure, means adjusted EBIT divided by segment net sales.

Acquired intangible asset amortization expense is a non-cash expense related to acquired operations that management believes is not indicative of the on-going performance of the acquired operations. Since the Company’s U.S. pension plans are significantly over funded and have no required cash contributions for the foreseeable future based on current regulations, management views other pension (income) expense from the Company’s U.S. pension plans, which excludes service costs, as not reflective of the operational performance of the Company or its segments. While rationalization costs are incurred on a regular basis, management views these costs more as an investment to generate savings rather than period costs. Costs attributed to announced acquisitions consist of third party fees and expenses that are viewed by management as part of the acquisition and not indicative of the on-going cost structure of the Company.

-22-

A reconciliation of such non-GAAP financial measures for the periods presented is provided below:


	Three Months Ended				Nine Months Ended
	Sept. 30, 2024		Sept. 30, 2023		Sept. 30, 2024		Sept. 30, 2023

	(Dollars in millions)
Dispensing and Specialty Closures
Income before interest and income taxes (EBIT)	$	74.7	$	78.0	$	213.3	$	212.6
Acquired intangible asset amortization expense	10.9		11.8		33.6		35.4
Other pension (income) expense for U.S. pension plans	(0.2)		0.2		(0.7)		0.4
Rationalization charges	9.8		3.8		19.6		5.2

Adjusted EBIT	$	95.2	$	93.8	$	265.8	$	253.6

Metal Containers
Income before interest and income taxes (EBIT)	$	89.3	$	110.1	$	187.3	$	231.6
Acquired intangible asset amortization expense	0.4		0.4		1.0		1.1
Other pension (income) expense for U.S. pension plans	(0.5)		0.4		(1.7)		1.1
Rationalization charges	7.9		2.6		13.9		7.9

Adjusted EBIT	$	97.1	$	113.5	$	200.5	$	241.7

Custom Containers
Income before interest and income taxes (EBIT)	$	17.1	$	10.7	$	55.5	$	46.1
Acquired intangible asset amortization expense	1.1		1.1		3.4		3.4
Other pension (income) expense for U.S. pension plans	—		—		(0.7)		0.7
Rationalization charges	1.8		—		4.5		0.1

Adjusted EBIT	$	20.0	$	11.8	$	62.7	$	50.3

Corporate
Loss before interest and income taxes (EBIT)	$	(13.8)	$	(4.7)	$	(35.2)	$	(21.0)

Costs attributed to announced acquisitions	7.1		—		12.6		—
Adjusted EBIT	$	(6.7)	$	(4.7)	$	(22.6)	$	(21.0)

Total adjusted EBIT	$	205.6	$	214.4	$	506.4	$	524.6

-23-

Dispensing and Specialty Closures Segment


	Three Months Ended						Nine Months Ended
	Sept. 30, 2024			Sept. 30, 2023			Sept. 30, 2024			Sept. 30, 2023

	(Dollars in millions)

Net sales	$	563.7		$	559.1		$	1,665.0		$	1,699.1
Income before interest and income taxes (EBIT)	74.7			78.0			213.3			212.6
Income before interest and income taxes margin (EBIT margin)	13.3		%	14.0		%	12.8		%	12.5		%
Adjusted EBIT	$	95.2		$	93.8		$	265.8		$	253.6
Adjusted EBIT margin	16.9		%	16.8		%	16.0		%	14.9		%

In the third quarter of 2024, net sales for the dispensing and specialty closures segment increased $4.6 million, or 0.8 percent, as compared to the third quarter of 2023. This increase was primarily the result of a more favorable mix of products sold, partially offset by lower unit volumes of approximately one percent, the pass through of lower raw material costs and the impact of unfavorable foreign currency translation of approximately $2.0 million. Higher volumes for dispensing products were offset by lower volumes for beverage products.

In the first nine months of 2024, net sales for the dispensing and specialty closures segment decreased $34.1 million, or 2.0 percent, as compared to the first nine months of 2023. This decrease was primarily the result of lower unit volumes of approximately two percent, the pass through of lower raw material costs and the impact of unfavorable foreign currency translation of approximately $1.0 million, partially offset by a more favorable mix of products sold. The decrease in unit volumes was principally the result of lower volumes for closures for food and beverage markets primarily due to customer destocking priorities.

In the third quarter of 2024, adjusted EBIT of the dispensing and specialty closures segment increased $1.4 million as compared to the third quarter of 2023, and adjusted EBIT margin increased to 16.9 percent from 16.8 percent over the same periods. The increase in adjusted EBIT was primarily due to improved manufacturing productivity and cost performance and a more favorable mix of products sold, partially offset by the unfavorable impact of foreign currency and lower unit volumes.

In the first nine months of 2024, adjusted EBIT of the dispensing and specialty closures segment increased $12.2 million as compared to the first nine months of 2023, and adjusted EBIT margin increased to 16.0 percent from 14.9 percent over the same periods. The increase in adjusted EBIT was primarily due to improved manufacturing productivity and cost performance and a more favorable mix of products sold, partially offset by lower unit volumes.

-24-

Metal Containers Segment


	Three Months Ended						Nine Months Ended
	Sept. 30, 2024			Sept. 30, 2023			Sept. 30, 2024			Sept. 30, 2023

	(Dollars in millions)

Net sales	$	1,022.6		$	1,094.6		$	2,290.5		$	2,475.6
Income before interest and income taxes (EBIT)	89.3			110.1			187.3			231.6
Income before interest and income taxes margin (EBIT margin)	8.7		%	10.1		%	8.2		%	9.4		%
Adjusted EBIT	$	97.1		$	113.5		$	200.5		$	241.7
Adjusted EBIT margin	9.5		%	10.4		%	8.8		%	9.8		%

In the third quarter of 2024, net sales for the metal containers segment decreased $72.0 million, or 6.6 percent, as compared to the third quarter of 2023. This decrease was primarily the result of the contractual pass through of lower raw material costs as compared to the lagged contractual pass through of inflation in labor and other manufacturing costs in the prior year period and a significantly less favorable mix of products sold, partially offset by higher unit volumes of approximately two percent and the impact of favorable foreign currency translation of approximately $2.0 million. Higher volumes for the pet food markets were partially offset by lower volumes for fruit and vegetable markets which were negatively impacted by a planned reduction in volumes by a large pack customer to reduce its working capital and severe weather that prematurely ended the fruit and vegetable packs.

In the first nine months of 2024, net sales for the metal containers segment decreased $185.1 million, or 7.5 percent, as compared to the first nine months of 2023. This decrease was primarily the result of the contractual pass through of lower raw material costs as compared to the lagged contractual pass through of inflation in labor and other manufacturing costs in the prior year period and a less favorable mix of products sold, partially offset by the impact of favorable foreign currency translation of approximately $4.0 million.

In the third quarter of 2024, adjusted EBIT of the metal containers segment decreased $16.4 million as compared to the third quarter of 2023, and adjusted EBIT margin decreased to 9.5 percent from 10.4 percent for the same periods. The decrease in adjusted EBIT was primarily due to a significantly less favorable mix of products sold due to lower unit volumes for fruit and vegetable markets and higher selling, general and administrative costs, partially offset by higher unit volumes for pet food markets.

In the first nine months of 2024, adjusted EBIT of the metal containers segment decreased $41.2 million as compared to the first nine months of 2023, and adjusted EBIT margin decreased to 8.8 percent from 9.8 percent for the same periods. The decrease in adjusted EBIT was primarily due to the unfavorable impact of lower fixed cost absorption as a result of a significantly lower inventory build in the current year period due to a reduction in pack plans of a large fruit and vegetable customer to reduce its working capital, the unfavorable impact of selling higher cost inventory from the prior year in our European operations due to lower metal costs in 2024, a significantly less favorable mix of products sold and higher selling, general and administrative costs.

-25-

Custom Containers Segment


	Three Months Ended						Nine Months Ended
	Sept. 30, 2024			Sept. 30, 2023			Sept. 30, 2024			Sept. 30, 2023

	(Dollars in millions)

Net sales	$	158.8		$	149.4		$	488.0		$	473.4
Income before interest and income taxes (EBIT)	17.1			10.7			55.5			46.1
Income before interest and income taxes margin (EBIT margin)	10.8		%	7.2		%	11.4		%	9.7		%
Adjusted EBIT	$	20.0		$	11.8		$	62.7		$	50.3
Adjusted EBIT margin	12.6		%	7.9		%	12.8		%	10.6		%

In the third quarter of 2024, net sales for the custom containers segment increased $9.4 million, or 6.3 percent, as compared to the third quarter of 2023. This increase was principally due to higher volumes of approximately five percent primarily driven by the commercialization of new business awards and the pass through of higher raw material costs, partially offset by the impact of unfavorable foreign currency translation of approximately $1.0 million.

In the first nine months of 2024, net sales for the custom containers segment increased $14.6 million, or 3.1 percent, as compared to the first nine months of 2023. This increase was principally due to higher volumes of approximately three percent primarily as a result of the commercialization of new business awards and the pass through of higher raw material costs, partially offset by a less favorable mix of products sold and the impact of unfavorable foreign currency translation of approximately $1.0 million.

In the third quarter of 2024, adjusted EBIT of the custom containers segment increased $8.2 million as compared to the third quarter of 2023, and adjusted EBIT margin increased to 12.6 percent from 7.9 percent over the same periods. The increase in adjusted EBIT was primarily attributable to a more favorable mix of products sold and higher volumes.

In the first nine months of 2024, adjusted EBIT of the custom containers segment increased $12.4 million as compared to the first nine months of 2023, and adjusted EBIT margin increased to 12.8 percent from 10.6 percent over the same periods. The increase in adjusted EBIT was primarily attributable to a more favorable mix of products sold and higher volumes.

CAPITAL RESOURCES AND LIQUIDITY

Our principal sources of liquidity have been net cash from operating activities and borrowings under our debt instruments, including our senior secured credit facility. Our liquidity requirements arise from our obligations under the indebtedness incurred in connection with our acquisitions and the refinancing of that indebtedness, capital investment in new and existing equipment, the funding of our seasonal working capital needs and other general corporate uses.

On October 15, 2024, we acquired Weener, a leading producer of differentiated dispensing solutions for personal care, food and healthcare products. Weener operates a global network of 19 facilities predominantly in Europe and the Americas, with approximately 4,000 employees and proprietary manufacturing technologies including significant clean room capabilities. The purchase price for this acquisition of approximately $920.0 million, net of cash acquired, was funded with term and revolving loan borrowings under the Credit Agreement, including a new €700.0 million incremental term loan, and cash on hand.

On November 4, 2024, we and certain of our wholly owned subsidiaries entered into the Fifth Amendment with the Lenders therein and Wells Fargo Bank, National Association, as Administrative Agent. The Fifth Amendment:

-26-

•increased the aggregate amount of Euro term loans thereunder from €700.0 million to €900.0 million, with the additional €200.0 million of Euro term loans being used to repay revolving loans under the Credit Agreement that were used to fund a portion of the purchase price for Weener and to pay fees, expenses and costs associated with the Fifth Amendment.

•improved the interest rate margin grid for term loans;

•increased the uncommitted multi-currency incremental loan facility from $1.25 billion to $1.5 billion;

•amended certain covenants to provide additional flexibility; and

•amended certain other terms of the Credit Agreement.

Pursuant to the Fifth Amendment, total term loans of $1,854.4 million are repayable as follows: $18.5 million in 2025, $92.7 million in 2026, $185.4 million in each of 2027, 2028 and 2029, and $1,187.0 million in 2030 (non-U.S. dollar debt has been translated into U.S. dollars at exchange rates in effect at the balance sheet date).

As a result of the Fifth Amendment, we expect to record a pre-tax charge of approximately $0.9 million for the loss on early extinguishment of debt during the quarter ending December 31, 2024.

You should also read Note 15 to our Condensed Consolidated Financial Statements for the three and nine months ended September 30, 2024 included elsewhere in this quarterly report.

For the nine months ended September 30, 2024, we used net borrowings of revolving loans of $491.6 million and cash and cash equivalents of $274.4 million to fund cash used in operations of $213.9 million, decreases in outstanding checks of $160.6 million, the repayment of long-term debt of $100.0 million, net capital expenditures and other investing activities of $189.1 million, dividends paid on our common stock of $61.8 million, the repayment of principal amounts under finance leases of $27.3 million, repurchases of our common stock of $7.7 million and the negative effect of exchange rate changes on cash and cash equivalents of $5.6 million.

For the nine months ended September 30, 2023, we used net borrowings of revolving loans and proceeds from other foreign long-term debt of an aggregate of $847.5 million and cash and cash equivalents of $278.5 million (including the positive effect of exchange rate changes of $0.5 million) to fund cash used in operations of $596.0 million, repurchases of our common stock of $183.9 million, net capital expenditures and other investing activities of $170.6 million, decreases in outstanding checks of $61.4 million, dividends paid on our common stock of $59.7 million, the repayment of long-term debt of $52.7 million and the repayment of principal amounts under finance leases of $2.2 million.

At September 30, 2024, we had $505.0 million of revolving loans outstanding under the Credit Agreement. After taking into account outstanding letters of credit, the available portion of revolving loans under the Credit Agreement at September 30, 2024 was $974.4 million.

Because we sell metal containers and closures used in fruit and vegetable pack processing, we have seasonal sales. As is common in the industry, we must utilize working capital to build inventory and then carry accounts receivable for some customers beyond the end of the packing season. Due to our seasonal requirements, which generally peak sometime in the summer or early fall, we may incur short-term indebtedness to finance our working capital requirements. Our peak seasonal working capital requirements have historically averaged approximately $375 million. We fund seasonal working capital requirements through revolving loans under the Credit Agreement, other foreign bank loans and cash on hand. We may use the available portion of revolving loans under the Credit Agreement, after taking into account our seasonal needs and outstanding letters of credit, for other general corporate purposes including acquisitions, capital expenditures, dividends, stock repurchases and to refinance or repurchase other debt.

We believe that cash generated from operations and funds from borrowings available under the Credit Agreement and other foreign bank loans will be sufficient to meet our expected operating needs, planned capital expenditures, debt service, tax obligations, pension benefit plan contributions, share repurchases and common stock dividends for the foreseeable future. We continue to evaluate acquisition opportunities in the consumer goods packaging market and may incur additional indebtedness, including indebtedness under the Credit Agreement, to finance any such acquisition.

We are in compliance with all financial and operating covenants contained in our financing agreements and believe that we will continue to be in compliance during 2024 with all of these covenants.

-27-

Supply Chain Finance Program

For our suppliers, we believe that we negotiate the best terms possible, including payment terms. In connection therewith, we initiated a SCF program with a major global financial institution. Under this SCF program, a qualifying supplier may elect, but is not obligated, to sell its receivables from us to such financial institution. A participating supplier negotiates its receivables sale arrangements directly with the financial institution under this SCF program. While we are not party to, and do not participate in the negotiation of, such arrangements, such financial institution allows a participating supplier to utilize our creditworthiness in establishing a credit spread in respect of the sale of its receivables from us as well as other applicable terms. This may provide a supplier with more favorable terms than it would be able to secure on its own. We have no economic interest in a supplier’s decision to sell a receivable. Once a qualifying supplier elects to participate in this SCF program and reaches an agreement with the financial institution, the supplier independently elects which individual invoices to us that they sell to the financial institution. All of our payments to a participating supplier are paid to the financial institution on the invoice due date under our agreement with such supplier, regardless of whether the individual invoice was sold by the supplier to the financial institution. The financial institution then pays the supplier on the invoice due date under our agreement with such supplier for any invoices not previously sold by the supplier to the financial institution. Amounts due to a supplier that elects to participate in this SCF program are included in accounts payable in our Condensed Consolidated Balance Sheet, and the associated payments are reflected in net cash provided by operating activities in our Condensed Consolidated Statements of Cash Flows. Separate from this SCF program, we and suppliers who participate in this SCF program generally maintain the contractual right to require the other party to negotiate in good faith the existing payment terms as a result of changes in market conditions, including changes in interest rates and general market liquidity, or in some cases for any reason. Outstanding trade accounts payables subject to this SCF program were approximately $284.2 million, $294.1 million and $330.2 million at September 30, 2024 and 2023 and December 31, 2023, respectively.

Guaranteed Securities

Each of the 3¼% Senior Notes, the 4⅛% Senior Notes, the 2¼% Senior Notes and the 1.4% Senior Secured Notes were issued by Silgan and are guaranteed by our U.S. subsidiaries that also guarantee our obligations under the Credit Agreement, collectively the Obligor Group.

The following summarized financial information relates to the Obligor Group as of September 30, 2024 and December 31, 2023 and for the nine months ended September 30, 2024. Intercompany transactions, equity investments and other intercompany activity within the Obligor Group have been eliminated from the summarized financial information. Investments in subsidiaries of Silgan that are not part of the Obligor Group of $1.7 billion and $1.6 billion as of September 30, 2024 and December 31, 2023, respectively, are not included in noncurrent assets in the table below.



	Sept. 30, 2024	Dec. 31, 2023
	(Dollars in millions)

Current assets	$1,496.7	$1,403.5
Noncurrent assets	3,949.6	3,988.8
Current liabilities	1,971.8	1,967.8
Noncurrent liabilities	3,100.7	3,123.8

At September 30, 2024 and December 31, 2023, the Obligor Group held current receivables due from other subsidiary companies of $19.7 million and $35.6 million, respectively; long-term notes receivable due from other subsidiary companies of $755.3 million and $748.8 million, respectively; and current payables due to other subsidiary companies of $14.5 million and $10.9 million, respectively.

-28-

Nine Months Ended

Sept. 30, 2024

(Dollars in millions)

Net sales

$3,284.2

Gross profit

484.7

Net income

144.3

For the nine months ended September 30, 2024, net income in the table above excludes income from equity method investments of other subsidiary companies of $87.1 million. For the nine months ended September 30, 2024, the Obligor Group recorded the following transactions with other subsidiary companies: sales to such other subsidiary companies of $40.9 million; net credits from such other subsidiary companies of $19.5 million; and net interest income from such other subsidiary companies of $28.4 million. For the nine months ended September 30, 2024, the Obligor Group did not receive dividends from other subsidiary companies.

Rationalization Charges

We continually evaluate cost reduction opportunities across each of our segments, including rationalizations of our existing facilities through plant closings and downsizings. We use a disciplined approach to identify opportunities that generate attractive cash returns. Under our rationalization plans, we made cash payments of $31.2 million and $8.9 million for the nine months ended September 30, 2024 and 2023, respectively. Excluding the impact of our withdrawal from the Central States Pension Plan in 2019, remaining expenses and cash expenditures for our rationalization plans are expected to be $6.9 million and $9.5 million, respectively. Remaining expenses for the accretion of interest for the withdrawal liability related to the Central States Pension Plan are expected to average approximately $0.8 million per year and be recognized annually through 2040, and remaining cash expenditures for the withdrawal liability related to the Central States Pension Plan are expected to be approximately $2.6 million annually through 2040.

You should also read Note 3 to our Condensed Consolidated Financial Statements for the three and nine months ended September 30, 2024 included elsewhere in this Quarterly Report.

-29-

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Market risks relating to our operations result primarily from changes in interest rates and, with respect to our international operations, in foreign currency exchange rates. In the normal course of business, we also have risk related to commodity price changes for items such as natural gas. We employ established policies and procedures to manage our exposure to these risks. Interest rate, foreign currency and commodity pricing transactions are used only to the extent considered necessary to meet our objectives. We do not utilize derivative financial instruments for trading or other speculative purposes.

Information regarding our interest rate risk, foreign currency exchange rate risk and commodity pricing risk has been disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023. Since such filing, other than the changes discussed in Notes 7 and 15 to our Condensed Consolidated Financial Statements for the three and nine months ended September 30, 2024 included elsewhere in this Quarterly Report, there has not been a material change to our interest rate risk, foreign currency exchange rate risk or commodity pricing risk or to our policies and procedures to manage our exposure to these risks.

Item 4. CONTROLS AND PROCEDURES

As required by Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, we carried out an evaluation, under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures. Based upon that evaluation, as of the end of the period covered by this Quarterly Report, our Chief Executive Officer and Chief Financial Officer concluded that the disclosure controls and procedures were effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that our disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including the Principal Executive Officer and the Principal Financial Officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

There were no changes in our internal controls over financial reporting during the period covered by this Quarterly Report that have materially affected, or are reasonably likely to materially affect, these internal controls.

-30-

Part II. Other Information

Item 5. Other Information

In the third quarter of 2024, none of our directors or officers adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K.

Item 6. Exhibits


Exhibit Number						Description


22						Subsidiary Guarantors and Issuers of Guaranteed Securities (incorporated by reference to Exhibit 22 filed with our Annual Report on Form 10-K for the year ended December 31, 2023, Commission File No. 001-41459).

*31.1						Certification by the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act.

*31.2						Certification by the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act.

*32.1						Certification by the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act.

*32.2						Certification by the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act.

101.INS						XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH						Inline XBRL Taxonomy Extension Schema Document.

101.CAL						Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF						Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB						Inline XBRL Taxonomy Extension Label Linkbase Document.

101.PRE						Inline XBRL Taxonomy Extension Presentation Linkbase Document.

104						Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).

___________________

*Filed herewith.

-31-

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Quarterly Report to be signed on its behalf by the undersigned thereunto duly authorized.


			SILGAN HOLDINGS INC.



Dated: November 7, 2024			/s/ Kimberly I. Ulmer
			Kimberly I. Ulmer
			Senior Vice President and
			Chief Financial Officer
			(Principal Financial and
			Accounting Officer)

-32-

Exhibit 31.1

CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT

I, Adam J. Greenlee, certify that:


1.			I have reviewed this Quarterly Report on Form 10-Q for the period ended September 30, 2024 of Silgan Holdings Inc.;


2.			Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.			Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.			The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a.			Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b.			Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c.			Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d.			Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.			The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):


a.			All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


b.			Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: November 7, 2024			/s/ Adam J. Greenlee
			Adam J. Greenlee
			Chief Executive Officer and President

Exhibit 31.2

CERTIFICATION BY THE CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT

I, Kimberly I. Ulmer, certify that:


1.			I have reviewed this Quarterly Report on Form 10-Q for the period ended September 30, 2024 of Silgan Holdings Inc.;


2.			Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.			Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.			The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a.			Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b.			Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c.			Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d.			Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.			The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):


a.			All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


b.			Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: November 7, 2024			/s/ Kimberly I. Ulmer
			Kimberly I. Ulmer
			Senior Vice President and
			Chief Financial Officer

Exhibit 32.1

CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT

In connection with the Quarterly Report of Silgan Holdings Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Quarterly Report”), I, Adam J. Greenlee, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:


			(1) The Quarterly Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
			(2) The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ Adam J. Greenlee
Adam J. Greenlee
Chief Executive Officer and President

November 7, 2024

A signed original of this written statement required by Section 906 has been provided to Silgan Holdings Inc. and will be retained by Silgan Holdings Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

Exhibit 32.2

CERTIFICATION BY THE CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT

In connection with the Quarterly Report of Silgan Holdings Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Quarterly Report”), I, Kimberly I. Ulmer, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:


			(1) The Quarterly Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
			(2) The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ Kimberly I. Ulmer
Kimberly I. Ulmer
Senior Vice President and
Chief Financial Officer

November 7, 2024

Cover - shares	9 Months Ended
Cover - shares	Sep. 30, 2024	Oct. 31, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	001-41459
Entity Registrant Name	SILGAN HOLDINGS INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	06-1269834
Entity Address, Address Line One	4 Landmark Square
Entity Address, City or Town	Stamford,
Entity Address, State or Province	CT
Entity Address, Postal Zip Code	06901
City Area Code	203
Local Phone Number	975-7110
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	SLGN
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		106,794,650
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Entity Central Index Key	0000849869
Current Fiscal Year End Date	--12-31

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Current assets:
Cash and cash equivalents	$ 368,507	$ 642,923	$ 307,124
Trade accounts receivable, net	1,210,331	599,524	1,295,882
Inventories	780,443	940,808	919,013
Prepaid expenses and other current assets	160,207	165,727	139,803
Total current assets	2,519,488	2,348,982	2,661,822
Property, plant and equipment, net	1,956,004	1,961,585	1,911,638
Goodwill	2,024,055	2,018,241	1,979,693
Other intangible assets, net	681,454	721,023	724,340
Other assets, net	566,365	561,405	534,814
Assets, total	7,747,366	7,611,236	7,812,307
Current liabilities:
Revolving loans and current portion of long-term debt	1,254,391	880,315	897,809
Trade accounts payable	678,518	1,075,913	651,991
Accrued payroll and related costs	106,367	97,886	96,375
Accrued liabilities	266,486	257,742	269,386
Total current liabilities	2,305,762	2,311,856	1,915,561
Long-term debt	2,553,659	2,546,451	3,312,685
Deferred income taxes	420,921	433,666	380,250
Other liabilities	413,054	429,905	421,922
Stockholders’ equity:
Common stock	1,751	1,751	1,751
Paid-in capital	364,074	353,848	349,634
Retained earnings	3,378,093	3,208,237	3,163,161
Accumulated other comprehensive loss	(260,597)	(251,361)	(309,586)
Treasury stock	(1,429,351)	(1,423,117)	(1,423,071)
Total stockholders’ equity	2,053,970	1,889,358	1,781,889
Liabilities and equity	$ 7,747,366	$ 7,611,236	$ 7,812,307

Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Net sales	$ 1,745,124	$ 1,803,101	$ 4,443,527	$ 4,648,109
Cost of goods sold	1,451,831	1,517,183	3,670,751	3,874,100
Gross profit	293,293	285,918	772,776	774,009
Selling, general and administrative expenses	106,405	84,320	314,582	287,821
Rationalization charges	19,483	6,424	38,033	13,212
Other pension and postretirement expense (income)	118	1,083	(698)	3,664
Income before interest and income taxes	167,287	194,091	420,859	469,312
Less interest and other debt expense	41,871	47,264	121,861	130,822
Income before income taxes	125,416	146,827	298,998	338,490
Provision for income taxes	25,363	36,210	67,684	76,954
Net income	$ 100,053	$ 110,617	$ 231,314	$ 261,536
Earnings per share
Basic net income per share (usd per share)	$ 0.94	$ 1.02	$ 2.17	$ 2.39
Diluted net income per share (usd per share)	$ 0.93	$ 1.02	$ 2.16	$ 2.38
Weighted average number of shares
Basic (in shares)	106,847	108,421	106,776	109,583
Effect of dilutive securities (in shares)	290	331	292	428
Diluted (in shares)	107,137	108,752	107,068	110,011

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Net income	$ 100,053	$ 110,617	$ 231,314	$ 261,536
Other comprehensive income (loss), net of tax:
Changes in net prior service credit and actuarial losses	1,719	1,995	4,533	5,518
Change in fair value of derivatives	(3,767)	1,865	(815)	5,230
Foreign currency translation	38,981	(33,892)	(12,954)	24,976
Other comprehensive income (loss)	36,933	(30,032)	(9,236)	35,724
Comprehensive income	$ 136,986	$ 80,585	$ 222,078	$ 297,260

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows provided by (used in) operating activities:
Net income	$ 231,314	$ 261,536
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	198,648	196,722
Amortization of debt discount and debt issuance costs	4,043	4,025
Rationalization charges	38,033	13,212
Stock compensation expense	11,727	11,348
Other changes that provided (used) cash:
Trade accounts receivable, net	(614,632)	(638,282)
Inventories	160,756	(152,891)
Trade accounts payable	(213,088)	(233,724)
Accrued liabilities	(6,978)	(31,055)
Other, net	(23,711)	(26,933)
Net cash (used in) operating activities	(213,888)	(596,042)
Cash flows provided by (used in) investing activities:
Capital expenditures	(192,035)	(173,453)
Proceeds from asset sales	3,221	1,628
Other, net	(293)	1,267
Net cash (used in) investing activities	(189,107)	(170,558)
Cash flows provided by (used in) financing activities:
Borrowings under revolving loans	802,389	1,119,960
Repayments under revolving loans	(310,827)	(281,067)
Repayment of principal amounts under finance leases	(27,281)	(2,208)
Proceeds from issuance of long-term debt	0	8,649
Repayments of long-term debt	(100,000)	(52,650)
Changes in outstanding checks - principally vendors	(160,576)	(61,433)
Dividends paid on common stock	(61,754)	(59,712)
Repurchase of common stock	(7,735)	(183,939)
Net cash provided by financing activities	134,216	487,600
Effect of exchange rate changes on cash and cash equivalents	(5,637)	502
Cash and cash equivalents:
Net (decrease)	(274,416)	(278,498)
Balance at beginning of year	642,923	585,622
Balance at end of period	368,507	307,124
Interest paid, net	133,411	123,944
Income taxes paid, net	$ 69,748	$ 95,911

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common stock	Paid-in capital	Retained earnings	Accumulated other comprehensive loss	Treasury stock
Beginning balance at Dec. 31, 2022		$ 1,751	$ 339,839	$ 2,961,079	$ (345,310)	$ (1,239,103)
Beginning balance (in shares) at Dec. 31, 2022		110,079
Increase (Decrease) in Stockholders' Equity
Net issuance of treasury stock for vested restricted stock units (in shares)		312
Repurchases of common stock (in shares)		(3,893)
Stock compensation expense			11,348
Net issuance of treasury stock for vested restricted stock units			(1,553)			(7,664)
Net income	$ 261,536			261,536
Dividends declared on common stock				(59,454)
Other comprehensive income (loss)					35,724
Repurchases of common stock						(176,304)
Ending balance at Sep. 30, 2023	$ 1,781,889	$ 1,751	349,634	3,163,161	(309,586)	(1,423,071)
Ending balance (in shares) at Sep. 30, 2023		106,498
Increase (Decrease) in Stockholders' Equity
Dividends declared on common stock per share (usd per share)	$ 0.54
Beginning balance at Jun. 30, 2023		$ 1,751	345,442	3,072,021	(279,554)	(1,268,524)
Beginning balance (in shares) at Jun. 30, 2023		109,946
Increase (Decrease) in Stockholders' Equity
Net issuance of treasury stock for vested restricted stock units (in shares)		0
Repurchases of common stock (in shares)		(3,448)
Stock compensation expense			4,192
Net issuance of treasury stock for vested restricted stock units			0			0
Net income	$ 110,617			110,617
Dividends declared on common stock				(19,477)
Other comprehensive income (loss)					(30,032)
Repurchases of common stock						(154,547)
Ending balance at Sep. 30, 2023	$ 1,781,889	$ 1,751	349,634	3,163,161	(309,586)	(1,423,071)
Ending balance (in shares) at Sep. 30, 2023		106,498
Increase (Decrease) in Stockholders' Equity
Dividends declared on common stock per share (usd per share)	$ 0.18
Beginning balance at Dec. 31, 2023	$ 1,889,358	$ 1,751	353,848	3,208,237	(251,361)	(1,423,117)
Beginning balance (in shares) at Dec. 31, 2023		106,500
Increase (Decrease) in Stockholders' Equity
Net issuance of treasury stock for vested restricted stock units (in shares)		295
Repurchases of common stock (in shares)		0
Stock compensation expense			11,727
Net issuance of treasury stock for vested restricted stock units			(1,501)			(6,234)
Net income	231,314			231,314
Dividends declared on common stock				(61,458)
Other comprehensive income (loss)					(9,236)
Repurchases of common stock						0
Ending balance at Sep. 30, 2024	$ 2,053,970	$ 1,751	364,074	3,378,093	(260,597)	(1,429,351)
Ending balance (in shares) at Sep. 30, 2024		106,795
Increase (Decrease) in Stockholders' Equity
Dividends declared on common stock per share (usd per share)	$ 0.57
Beginning balance at Jun. 30, 2024		$ 1,751	360,344	3,298,525	(297,530)	(1,429,400)
Beginning balance (in shares) at Jun. 30, 2024		106,779
Increase (Decrease) in Stockholders' Equity
Net issuance of treasury stock for vested restricted stock units (in shares)		16
Repurchases of common stock (in shares)		0
Stock compensation expense			3,779
Net issuance of treasury stock for vested restricted stock units			(49)			49
Net income	$ 100,053			100,053
Dividends declared on common stock				(20,485)
Other comprehensive income (loss)					36,933
Repurchases of common stock						0
Ending balance at Sep. 30, 2024	$ 2,053,970	$ 1,751	$ 364,074	$ 3,378,093	$ (260,597)	$ (1,429,351)
Ending balance (in shares) at Sep. 30, 2024		106,795
Increase (Decrease) in Stockholders' Equity
Dividends declared on common stock per share (usd per share)	$ 0.19

Significant Accounting Policies	9 Months Ended
Significant Accounting Policies	Sep. 30, 2024
Accounting Policies [Abstract]
Significant Accounting Policies	Significant Accounting Policies Basis of Presentation. The accompanying unaudited condensed consolidated financial statements of Silgan Holdings Inc., or Silgan, have been prepared in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the accompanying financial statements include all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation. The results of operations for any interim period are not necessarily indicative of the results of operations for the full year. The Condensed Consolidated Balance Sheet at December 31, 2023 has been derived from our audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements. You should read the accompanying condensed consolidated financial statements in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2023. Certain prior year amounts have been reclassified to conform with the current year's presentation. Goodwill and Other Intangible Assets. We review goodwill and other indefinite-lived intangible assets for impairment as of July 1 of each year and more frequently if circumstances indicate a possible impairment. We determined that our goodwill and other indefinite-lived intangible assets were not impaired in our annual 2024 assessment performed during the third quarter.

Revenue

9 Months Ended

Sep. 30, 2024

Revenue from Contract with Customer [Abstract]

Revenue


	Three Months Ended				Nine Months Ended
	Sept. 30, 2024		Sept. 30, 2023		Sept. 30, 2024		Sept. 30, 2023

	(Dollars in thousands)
Dispensing and Specialty Closures	$	563,669	$	559,081	$	1,664,966	$	1,699,109
Metal Containers	1,022,605		1,094,609		2,290,530		2,475,569
Custom Containers	158,850		149,411		488,031		473,431
	$	1,745,124	$	1,803,101	$	4,443,527	$	4,648,109

Revenues by geography were as follows:


	Three Months Ended				Nine Months Ended
	Sept. 30, 2024		Sept. 30, 2023		Sept. 30, 2024		Sept. 30, 2023

	(Dollars in thousands)
North America	$	1,368,104	$	1,437,539	$	3,384,468	$	3,555,971
Europe and other	377,020		365,562		1,059,059		1,092,138
	$	1,745,124	$	1,803,101	$	4,443,527	$	4,648,109

Rationalization Charges

9 Months Ended

Sep. 30, 2024

Restructuring and Related Activities [Abstract]

Rationalization Charges


	Three Months Ended				Nine Months Ended
	Sept. 30, 2024		Sept. 30, 2023		Sept. 30, 2024		Sept. 30, 2023

	(Dollars in thousands)
Dispensing and Specialty Closures	$	9,835	$	3,836	$	19,583	$	5,164
Metal Containers	7,850		2,588		13,927		7,944
Custom Containers	1,798		—		4,523		104
	$	19,483	$	6,424	$	38,033	$	13,212

Activity in reserves for our rationalization plans were as follows:


	Employee Severance and Benefits		Plant Exit Costs		Non-Cash Asset Write-Downs		Total
	(Dollars in thousands)
Balance at December 31, 2023	$	33,555	$	465	$	—	$	34,020
Charged to expense	6,723		19,942		11,368		38,033
Utilized and currency translation	(10,842)		(20,407)		(11,368)		(42,617)
Balance at September 30, 2024	$	29,436	$	—	$	—	$	29,436

Accumulated Other Comprehensive Loss

9 Months Ended

Sep. 30, 2024

Equity [Abstract]

Accumulated Other Comprehensive Loss


	Unrecognized Net Defined Benefit Plan Costs		Change in Fair Value of Derivatives		Foreign Currency Translation		Total
	(Dollars in thousands)
Balance at December 31, 2023	$	(133,523)	$	(216)	$	(117,622)	$	(251,361)
Other comprehensive loss before reclassifications	—		837		(12,954)		(12,117)
Amounts reclassified from accumulated other comprehensive loss	4,533		(1,652)		—		2,881
Other comprehensive loss	4,533		(815)		(12,954)		(9,236)
Balance at September 30, 2024	$	(128,990)	$	(1,031)	$	(130,576)	$	(260,597)

Inventories

9 Months Ended

Sep. 30, 2024

Inventory Disclosure [Abstract]

Inventories

Inventories consisted of the following:


	Sept. 30, 2024		Sept. 30, 2023		Dec. 31, 2023
	(Dollars in thousands)
Raw materials	$	400,916	$	460,137	$	465,375
Work-in-process	192,986		220,164		219,462
Finished goods	486,641		565,790		556,737
Other	17,282		17,234		16,616
	1,097,825		1,263,325		1,258,190
Adjustment to value inventory at cost on the LIFO method	(317,382)		(344,312)		(317,382)
	$	780,443	$	919,013	$	940,808

Long-Term Debt

9 Months Ended

Sep. 30, 2024

Debt Disclosure [Abstract]

Long-Term Debt

Long-term debt consisted of the following:


	Sept. 30, 2024		Sept. 30, 2023		Dec. 31, 2023
	(Dollars in thousands)
Bank debt
Bank revolving loans	$	505,000	$	818,000	$	—
U.S. term loans	850,000		950,000		950,000

Other foreign bank revolving and term loans	43,127		75,502		56,243
Total bank debt	1,398,127		1,843,502		1,006,243



3¼% Senior Notes	725,400		688,155		717,990
4⅛% Senior Notes	600,000		600,000		600,000
2¼% Senior Notes	558,000		529,350		552,300
1.4% Senior Secured Notes	500,000		500,000		500,000
Finance leases	36,342		63,663		63,302
Total debt - principal	3,817,869		4,224,670		3,439,835
Less unamortized debt issuance costs and debt discount	9,819		14,176		13,069
Total debt	3,808,050		4,210,494		3,426,766
Less current portion	1,254,391		897,809		880,315
	$	2,553,659	$	3,312,685	$	2,546,451

Financial Instruments

9 Months Ended

Sep. 30, 2024

Investments, All Other Investments [Abstract]

Financial Instruments


	Carrying Amount		Fair Value
	(Dollars in thousands)
Assets:
Cash and cash equivalents	$	368,507	$	368,507


Liabilities:
Bank debt	$	1,398,127	$	1,398,127


3¼% Senior Notes	725,400		723,949
4⅛% Senior Notes	599,532		585,354
2¼% Senior Notes	558,000		524,609
1.4% Senior Secured Notes	499,916		474,235

Fair Value Measurements

Financial Instruments Measured at Fair Value

Financial Instruments Not Measured at Fair Value

Derivative Instruments and Hedging Activities

Interest Rate Swap Agreements

Natural Gas Swap Agreements

Foreign Currency Exchange Rate Risk

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies We are a party to other legal proceedings, contract disputes and claims arising in the ordinary course of our business. We are not a party to, and none of our properties are subject to, any pending legal proceedings which could have a material adverse effect on our business or financial condition.

Supply Chain Finance Program	9 Months Ended
Supply Chain Finance Program	Sep. 30, 2024
Payables and Accruals [Abstract]
Supply Chain Finance Program	Supply Chain Finance Program We have a supply chain finance (“SCF”) program with a major global financial institution. Under this SCF program, a qualifying supplier may elect, but is not obligated, to sell its receivables from us to such financial institution. Once a qualifying supplier elects to participate in this SCF program, all of our payments to the participating supplier are paid to such financial institution in this SCF program on the invoice due date under our agreement with such supplier, regardless of whether the individual invoice was sold by the supplier to such financial institution. We may terminate our agreement with the financial institution upon at least 30 days’ notice, and the financial institution may terminate our agreement upon at least 10 days’ notice. Additionally, suppliers who elect to participate in this SCF program may terminate their participation upon at least 30 days’ notice. The suppliers' invoices sold under this SCF program can be outstanding up to 210 days from the invoice date. Suppliers’ invoices included in this SCF program were $284.2 million, $294.1 million and $330.2 million at September 30, 2024 and 2023 and December 31, 2023, respectively, and were included in accounts payable in our Condensed Consolidated Balance Sheets.

Retirement Benefits

9 Months Ended

Sep. 30, 2024

Retirement Benefits [Abstract]

Retirement Benefits

The components of the net periodic pension benefit cost were as follows:


	Three Months Ended				Nine Months Ended
	Sept. 30, 2024		Sept. 30, 2023		Sept. 30, 2024		Sept. 30, 2023

	(Dollars in thousands)
Service cost	$	1,990	$	1,962	$	6,319	$	6,425
Interest cost	8,592		8,617		25,413		26,050
Expected return on plan assets	(10,772)		(10,211)		(32,314)		(30,587)
Amortization of prior service cost	22		29		68		82
Amortization of actuarial losses	2,232		2,845		5,937		8,729

Net periodic benefit cost	$	2,064	$	3,242	$	5,423	$	10,699

The components of the net periodic other postretirement benefit cost (credit) were as follows:


	Three Months Ended				Nine Months Ended
	Sept. 30, 2024		Sept. 30, 2023		Sept. 30, 2024		Sept. 30, 2023

	(Dollars in thousands)
Service cost	$	8	$	12	$	22	$	38
Interest cost	151		181		483		559
Amortization of prior service credit	(5)		(237)		(15)		(705)
Amortization of actuarial gains	(102)		(141)		(270)		(464)
Net periodic benefit cost (credit)	$	52	$	(185)	$	220	$	(572)

Income Taxes	9 Months Ended
Income Taxes	Sep. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income TaxesSilgan and its subsidiaries file U.S. Federal income tax returns, as well as income tax returns in various states and foreign jurisdictions. The Internal Revenue Service, or IRS, has completed its review of the 2022 tax year with no change to our filed federal income tax return. We have been accepted into the Compliance Assurance Program for the 2023 and 2024 tax years which provides for the review by the IRS of tax matters relating to our tax return prior to filing.

Treasury Stock	9 Months Ended
Treasury Stock	Sep. 30, 2024
Equity [Abstract]
Treasury Stock	Treasury Stock On March 4, 2022, our Board of Directors authorized the repurchase by us of up to an aggregate of $300.0 million of our common stock by various means from time to time through and including December 31, 2026. We did not repurchase any shares of our common stock pursuant to this authorization during the nine months ended September 30, 2024. At September 30, 2024, we had approximately $93.3 million remaining under this authorization for the repurchase of our common stock. During the first nine months of 2024, we issued 470,788 treasury shares which had an average cost of $3.19 per share for restricted stock units that vested during the period that had been previously issued under our stock-based compensation plans. In accordance with the applicable agreements for such restricted stock units, we repurchased 176,093 shares of our common stock at an average cost of $43.92 to satisfy minimum employee withholding tax requirements resulting from the vesting of such restricted stock units. We account for treasury shares using the first-in, first-out (FIFO) cost method. As of September 30, 2024, 68,317,846 shares of our common stock were held in treasury.

Stock-Based Compensation	9 Months Ended
Stock-Based Compensation	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation We currently have one stock-based compensation plan in effect under which we have issued restricted stock units to our officers, other key employees and outside directors. During the first nine months of 2024, 490,672 restricted stock units were granted to certain of our officers, other key employees and outside directors. The fair value of these restricted stock units at the grant date was $21.6 million, which is being amortized ratably over the respective vesting period from the grant date.

Segment Information

9 Months Ended

Sep. 30, 2024

Segment Reporting [Abstract]

Segment Information

Reportable segment information was as follows:


	Dispensing and Specialty Closures		Metal Containers		Custom Containers		Corporate		Total
	(Dollars in thousands)
Three Months Ended September 30, 2024
Net sales	$	563,669	$	1,022,605	$	158,850	$	—	$	1,745,124
Income before interest and income taxes	74,659		89,307		17,136		(13,815)		167,287
Adjusted EBIT	95,216		97,065		20,011		(6,704)		205,588
Depreciation	25,755		19,801		8,747		47		54,350

Three Months Ended September 30, 2023
Net sales	$	559,081	$	1,094,609	$	149,411	$	—	$	1,803,101
Income before interest and income taxes	77,949		110,185		10,668		(4,711)		194,091
Adjusted EBIT	93,786		113,519		11,839		(4,711)		214,433
Depreciation	25,691		18,177		8,089		8		51,965

Nine Months Ended September 30, 2024
Net sales	$	1,664,966	$	2,290,530	$	488,031	$	—	$	4,443,527
Income before interest and income taxes	213,320		187,290		55,464		(35,215)		420,859
Adjusted EBIT	265,773		200,532		62,724		(22,597)		506,432
Depreciation	76,290		57,606		26,634		115		160,645

Nine Months Ended September 30, 2023
Net sales	$	1,699,109	$	2,475,569	$	473,431	$	—	$	4,648,109
Income before interest and income taxes	212,612		231,563		46,082		(20,945)		469,312
Adjusted EBIT	253,604		241,659		50,317		(20,945)		524,635
Depreciation	76,206		54,693		25,923		66		156,888

Total adjusted EBIT is reconciled to income before income taxes as follows:


	Three Months Ended				Nine Months Ended
	Sept. 30, 2024		Sept. 30, 2023		Sept. 30, 2024		Sept. 30, 2023

	(Dollars in thousands)
Total adjusted EBIT	$	205,588	$	214,433	$	506,432	$	524,635
Less:
Acquired intangible asset amortization expense	12,367		13,309		38,004		39,834
Other pension (income) expense for U.S. pension plans	(660)		609		(3,082)		2,277
Rationalization charges	19,483		6,424		38,033		13,212
Costs attributed to announced acquisitions	7,111		—		12,618		—

Income before interest and income taxes	167,287		194,091		420,859		469,312
Less interest and other debt expense	41,871		47,264		121,861		130,822
Income before income taxes	$	125,416	$	146,827	$	298,998	$	338,490

Subsequent Events	9 Months Ended
Subsequent Events	Sep. 30, 2024
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Weener Plastics Holding B.V. Acquisition On October 15, 2024, we acquired Weener Plastics Holding B.V., or Weener, a leading producer of differentiated dispensing solutions for personal care, food and healthcare products. Weener operates a global network of 19 facilities predominantly in Europe and the Americas, with approximately 4,000 employees and proprietary manufacturing technologies including significant clean room capabilities. The purchase price for this acquisition of approximately €844.2 million, net of cash acquired, was funded with term and revolving loan borrowings under the Credit Agreement, including a new €700.0 million incremental term loan, and cash on hand. Euro Interest Rate Swap Agreements In October 2024, we entered into €685.0 million aggregate notional principal amount of Euro interest rate swap agreements to manage a portion of our exposure to interest rate fluctuations for our Euro term loans under the Credit Agreement, which mature as follows: €35.0 million in October 2026, €70.0 million in October 2027 and €580.0 million in October 2030. These agreements have a weighted average fixed rate of 2.43 percent and were entered into with financial institutions which are expected to fully perform under the terms thereof. Amendment to Bank Credit Agreement On November 4, 2024, we and certain of our wholly owned subsidiaries amended the Credit Agreement by entering into a Fifth Amendment to Amended and Restated Credit Agreement (the “Fifth Amendment”) with the Lenders therein and Wells Fargo Bank, National Association, as Administrative Agent. The Fifth Amendment: •refinanced outstanding term loans and revolving loans thereunder and extended the maturity dates to (i) November 4, 2029 with respect to revolving loans and (ii) November 4, 2030 with respect to term loans; •increased the aggregate amount of Euro term loans thereunder from €700.0 million to €900.0 million, with the additional €200.0 million of Euro term loans being used to repay revolving loans under the Credit Agreement that were used to fund a portion of the purchase price for Weener and to pay fees, expenses and costs associated with the Fifth Amendment. •removed the springing maturity date provisions that would have shortened the maturity dates under the Credit Agreement to the date that is 91 days prior to the maturity dates of the 3¼% Senior Notes and 1.4% Senior Secured Notes due 2026 (unless such notes were refinanced or repaid prior thereto); •improved the interest rate margin grid for term loans; •increased the uncommitted multi-currency incremental loan facility from $1.25 billion to $1.5 billion; •amended certain covenants to provide additional flexibility; and •amended certain other terms of the Credit Agreement. Pursuant to the Fifth Amendment, U.S. term loans are repayable in installments as follows: $8.5 million on December 31, 2025, $42.5 million on December 31, 2026, $85.0 million on each of December 31, 2027, 2028 and 2029 and $544.0 million on November 4, 2030, and Euro term loans are repayable in installments as follows: €9.0 million on December 31, 2025, €45.0 million on December 31, 2026, €90.0 million on each of December 31, 2027, 2028 and 2029 and €576.0 million on November 4, 2030.

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net income	$ 100,053	$ 110,617	$ 231,314	$ 261,536

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Sep. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Significant Accounting Policies (Policies)	9 Months Ended
Significant Accounting Policies (Policies)	Sep. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation. The accompanying unaudited condensed consolidated financial statements of Silgan Holdings Inc., or Silgan, have been prepared in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the accompanying financial statements include all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation. The results of operations for any interim period are not necessarily indicative of the results of operations for the full year. The Condensed Consolidated Balance Sheet at December 31, 2023 has been derived from our audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements. You should read the accompanying condensed consolidated financial statements in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2023. Certain prior year amounts have been reclassified to conform with the current year's presentation.
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets. We review goodwill and other indefinite-lived intangible assets for impairment as of July 1 of each year and more frequently if circumstances indicate a possible impairment. We determined that our goodwill and other indefinite-lived intangible assets were not impaired in our annual 2024 assessment performed during the third quarter.

Revenue (Tables)

9 Months Ended

Sep. 30, 2024

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

Revenues by segment were as follows:


	Three Months Ended				Nine Months Ended
	Sept. 30, 2024		Sept. 30, 2023		Sept. 30, 2024		Sept. 30, 2023

	(Dollars in thousands)
Dispensing and Specialty Closures	$	563,669	$	559,081	$	1,664,966	$	1,699,109
Metal Containers	1,022,605		1,094,609		2,290,530		2,475,569
Custom Containers	158,850		149,411		488,031		473,431
	$	1,745,124	$	1,803,101	$	4,443,527	$	4,648,109

Revenues by geography were as follows:


	Three Months Ended				Nine Months Ended
	Sept. 30, 2024		Sept. 30, 2023		Sept. 30, 2024		Sept. 30, 2023

	(Dollars in thousands)
North America	$	1,368,104	$	1,437,539	$	3,384,468	$	3,555,971
Europe and other	377,020		365,562		1,059,059		1,092,138
	$	1,745,124	$	1,803,101	$	4,443,527	$	4,648,109

Rationalization Charges (Tables)

9 Months Ended

Sep. 30, 2024

Restructuring and Related Activities [Abstract]

Activity in Rationalization Plan Reserves

Rationalization charges by segment were as follows:


	Three Months Ended				Nine Months Ended
	Sept. 30, 2024		Sept. 30, 2023		Sept. 30, 2024		Sept. 30, 2023

	(Dollars in thousands)
Dispensing and Specialty Closures	$	9,835	$	3,836	$	19,583	$	5,164
Metal Containers	7,850		2,588		13,927		7,944
Custom Containers	1,798		—		4,523		104
	$	19,483	$	6,424	$	38,033	$	13,212

Activity in reserves for our rationalization plans were as follows:


	Employee Severance and Benefits		Plant Exit Costs		Non-Cash Asset Write-Downs		Total
	(Dollars in thousands)
Balance at December 31, 2023	$	33,555	$	465	$	—	$	34,020
Charged to expense	6,723		19,942		11,368		38,033
Utilized and currency translation	(10,842)		(20,407)		(11,368)		(42,617)
Balance at September 30, 2024	$	29,436	$	—	$	—	$	29,436

Accumulated Other Comprehensive Loss (Tables)

9 Months Ended

Sep. 30, 2024

Equity [Abstract]

Amounts Included in Accumulated Other Comprehensive Loss, Net of Tax

Amounts included in accumulated other comprehensive loss, net of tax, were as follows:


	Unrecognized Net Defined Benefit Plan Costs		Change in Fair Value of Derivatives		Foreign Currency Translation		Total
	(Dollars in thousands)
Balance at December 31, 2023	$	(133,523)	$	(216)	$	(117,622)	$	(251,361)
Other comprehensive loss before reclassifications	—		837		(12,954)		(12,117)
Amounts reclassified from accumulated other comprehensive loss	4,533		(1,652)		—		2,881
Other comprehensive loss	4,533		(815)		(12,954)		(9,236)
Balance at September 30, 2024	$	(128,990)	$	(1,031)	$	(130,576)	$	(260,597)

Inventories (Tables)

9 Months Ended

Sep. 30, 2024

Inventory Disclosure [Abstract]

Inventories

Inventories consisted of the following:


	Sept. 30, 2024		Sept. 30, 2023		Dec. 31, 2023
	(Dollars in thousands)
Raw materials	$	400,916	$	460,137	$	465,375
Work-in-process	192,986		220,164		219,462
Finished goods	486,641		565,790		556,737
Other	17,282		17,234		16,616
	1,097,825		1,263,325		1,258,190
Adjustment to value inventory at cost on the LIFO method	(317,382)		(344,312)		(317,382)
	$	780,443	$	919,013	$	940,808

Long-Term Debt (Tables)

9 Months Ended

Sep. 30, 2024

Debt Disclosure [Abstract]

Long-term Debt

Long-term debt consisted of the following:


	Sept. 30, 2024		Sept. 30, 2023		Dec. 31, 2023
	(Dollars in thousands)
Bank debt
Bank revolving loans	$	505,000	$	818,000	$	—
U.S. term loans	850,000		950,000		950,000

Other foreign bank revolving and term loans	43,127		75,502		56,243
Total bank debt	1,398,127		1,843,502		1,006,243



3¼% Senior Notes	725,400		688,155		717,990
4⅛% Senior Notes	600,000		600,000		600,000
2¼% Senior Notes	558,000		529,350		552,300
1.4% Senior Secured Notes	500,000		500,000		500,000
Finance leases	36,342		63,663		63,302
Total debt - principal	3,817,869		4,224,670		3,439,835
Less unamortized debt issuance costs and debt discount	9,819		14,176		13,069
Total debt	3,808,050		4,210,494		3,426,766
Less current portion	1,254,391		897,809		880,315
	$	2,553,659	$	3,312,685	$	2,546,451

Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2024

Investments, All Other Investments [Abstract]

Summary of Carrying Amounts and Estimated Fair Values of Other Financial Instruments

The following table summarizes the carrying amounts and estimated fair values of our other financial instruments at September 30, 2024:


	Carrying Amount		Fair Value
	(Dollars in thousands)
Assets:
Cash and cash equivalents	$	368,507	$	368,507


Liabilities:
Bank debt	$	1,398,127	$	1,398,127


3¼% Senior Notes	725,400		723,949
4⅛% Senior Notes	599,532		585,354
2¼% Senior Notes	558,000		524,609
1.4% Senior Secured Notes	499,916		474,235

Retirement Benefits (Tables)

9 Months Ended

Sep. 30, 2024

Retirement Benefits [Abstract]

Components of Net Periodic Benefit Cost (Credit)

The components of the net periodic pension benefit cost were as follows:


	Three Months Ended				Nine Months Ended
	Sept. 30, 2024		Sept. 30, 2023		Sept. 30, 2024		Sept. 30, 2023

	(Dollars in thousands)
Service cost	$	1,990	$	1,962	$	6,319	$	6,425
Interest cost	8,592		8,617		25,413		26,050
Expected return on plan assets	(10,772)		(10,211)		(32,314)		(30,587)
Amortization of prior service cost	22		29		68		82
Amortization of actuarial losses	2,232		2,845		5,937		8,729

Net periodic benefit cost	$	2,064	$	3,242	$	5,423	$	10,699

The components of the net periodic other postretirement benefit cost (credit) were as follows:


	Three Months Ended				Nine Months Ended
	Sept. 30, 2024		Sept. 30, 2023		Sept. 30, 2024		Sept. 30, 2023

	(Dollars in thousands)
Service cost	$	8	$	12	$	22	$	38
Interest cost	151		181		483		559
Amortization of prior service credit	(5)		(237)		(15)		(705)
Amortization of actuarial gains	(102)		(141)		(270)		(464)
Net periodic benefit cost (credit)	$	52	$	(185)	$	220	$	(572)

Segment Information (Tables)

9 Months Ended

Sep. 30, 2024

Segment Reporting [Abstract]

Reportable Operating Segment Information

Reportable segment information was as follows:


	Dispensing and Specialty Closures		Metal Containers		Custom Containers		Corporate		Total
	(Dollars in thousands)
Three Months Ended September 30, 2024
Net sales	$	563,669	$	1,022,605	$	158,850	$	—	$	1,745,124
Income before interest and income taxes	74,659		89,307		17,136		(13,815)		167,287
Adjusted EBIT	95,216		97,065		20,011		(6,704)		205,588
Depreciation	25,755		19,801		8,747		47		54,350

Three Months Ended September 30, 2023
Net sales	$	559,081	$	1,094,609	$	149,411	$	—	$	1,803,101
Income before interest and income taxes	77,949		110,185		10,668		(4,711)		194,091
Adjusted EBIT	93,786		113,519		11,839		(4,711)		214,433
Depreciation	25,691		18,177		8,089		8		51,965

Nine Months Ended September 30, 2024
Net sales	$	1,664,966	$	2,290,530	$	488,031	$	—	$	4,443,527
Income before interest and income taxes	213,320		187,290		55,464		(35,215)		420,859
Adjusted EBIT	265,773		200,532		62,724		(22,597)		506,432
Depreciation	76,290		57,606		26,634		115		160,645

Nine Months Ended September 30, 2023
Net sales	$	1,699,109	$	2,475,569	$	473,431	$	—	$	4,648,109
Income before interest and income taxes	212,612		231,563		46,082		(20,945)		469,312
Adjusted EBIT	253,604		241,659		50,317		(20,945)		524,635
Depreciation	76,206		54,693		25,923		66		156,888

Reconciliation of Adjusted EBIT to Income before Income Taxes

Total adjusted EBIT is reconciled to income before income taxes as follows:


	Three Months Ended				Nine Months Ended
	Sept. 30, 2024		Sept. 30, 2023		Sept. 30, 2024		Sept. 30, 2023

	(Dollars in thousands)
Total adjusted EBIT	$	205,588	$	214,433	$	506,432	$	524,635
Less:
Acquired intangible asset amortization expense	12,367		13,309		38,004		39,834
Other pension (income) expense for U.S. pension plans	(660)		609		(3,082)		2,277
Rationalization charges	19,483		6,424		38,033		13,212
Costs attributed to announced acquisitions	7,111		—		12,618		—

Income before interest and income taxes	167,287		194,091		420,859		469,312
Less interest and other debt expense	41,871		47,264		121,861		130,822
Income before income taxes	$	125,416	$	146,827	$	298,998	$	338,490

Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Revenue (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Segment Reporting Information [Line Items]
Net sales	$ 1,745,124	$ 1,803,101	$ 4,443,527	$ 4,648,109
Trade Accounts Receivable \| Unbilled Accounts Receivable
Segment Reporting Information [Line Items]
Contract assets	110,700	104,200	110,700	104,200	$ 100,000
North America
Segment Reporting Information [Line Items]
Net sales	1,368,104	1,437,539	3,384,468	3,555,971
Europe and other
Segment Reporting Information [Line Items]
Net sales	377,020	365,562	1,059,059	1,092,138
Dispensing and Specialty Closures
Segment Reporting Information [Line Items]
Net sales	563,669	559,081	1,664,966	1,699,109
Metal Containers
Segment Reporting Information [Line Items]
Net sales	1,022,605	1,094,609	2,290,530	2,475,569
Custom Containers
Segment Reporting Information [Line Items]
Net sales	$ 158,850	$ 149,411	$ 488,031	$ 473,431

Rationalization Charges - Rationalization Charges by Business Segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Restructuring Cost and Reserve [Line Items]
Rationalization charges	$ 19,483	$ 6,424	$ 38,033	$ 13,212
Dispensing and Specialty Closures
Restructuring Cost and Reserve [Line Items]
Rationalization charges	9,835	3,836	19,583	5,164
Metal Containers
Restructuring Cost and Reserve [Line Items]
Rationalization charges	7,850	2,588	13,927	7,944
Custom Containers
Restructuring Cost and Reserve [Line Items]
Rationalization charges	$ 1,798	$ 0	$ 4,523	$ 104

Rationalization Charges - Activity in Rationalization Plan Reserves (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Restructuring Reserve [Roll Forward]
Balance at December 31, 2023			$ 34,020
Charged to expense	$ 19,483	$ 6,424	38,033	$ 13,212
Utilized and currency translation			(42,617)
Balance at September 30, 2024	29,436		29,436
Employee Severance and Benefits
Restructuring Reserve [Roll Forward]
Balance at December 31, 2023			33,555
Charged to expense			6,723
Utilized and currency translation			(10,842)
Balance at September 30, 2024	29,436		29,436
Plant Exit Costs
Restructuring Reserve [Roll Forward]
Balance at December 31, 2023			465
Charged to expense			19,942
Utilized and currency translation			(20,407)
Balance at September 30, 2024	0		0
Non-Cash Asset Write-Downs
Restructuring Reserve [Roll Forward]
Balance at December 31, 2023			0
Charged to expense			11,368
Utilized and currency translation			(11,368)
Balance at September 30, 2024	$ 0		$ 0

Rationalization Charges - Narrative (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring reserve	$ 29,436	$ 34,020
Other Restructuring \| Rationalization Plan
Restructuring Cost and Reserve [Line Items]
Remaining expenses	6,900
Remaining cash expenditures	9,500
Annually Through 2040 \| Central States Pension Plan withdrawal
Restructuring Cost and Reserve [Line Items]
Remaining cash expenditures	2,600
Accretion expense	800
Accrued Liabilities
Restructuring Cost and Reserve [Line Items]
Restructuring reserve	3,600
Other Liabilities
Restructuring Cost and Reserve [Line Items]
Restructuring reserve	$ 25,800

Accumulated Other Comprehensive Loss - Amounts Included in Accumulated Other Comprehensive Loss, Net of Tax (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance			$ 1,889,358
Other comprehensive loss before reclassifications			(12,117)
Amounts reclassified from accumulated other comprehensive loss			2,881
Other comprehensive income (loss)	$ 36,933	$ (30,032)	(9,236)	$ 35,724
Ending balance	2,053,970	1,781,889	2,053,970	1,781,889
Accumulated other comprehensive loss
Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance	(297,530)	(279,554)	(251,361)	(345,310)
Ending balance	(260,597)	$ (309,586)	(260,597)	$ (309,586)
Unrecognized Net Defined Benefit Plan Costs
Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance			(133,523)
Other comprehensive loss before reclassifications			0
Amounts reclassified from accumulated other comprehensive loss			4,533
Other comprehensive income (loss)			4,533
Ending balance	(128,990)		(128,990)
Change in Fair Value of Derivatives
Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance			(216)
Other comprehensive loss before reclassifications			837
Amounts reclassified from accumulated other comprehensive loss			(1,652)
Other comprehensive income (loss)			(815)
Ending balance	(1,031)		(1,031)
Foreign Currency Translation
Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance			(117,622)
Other comprehensive loss before reclassifications			(12,954)
Amounts reclassified from accumulated other comprehensive loss			0
Other comprehensive income (loss)			(12,954)
Ending balance	$ (130,576)		$ (130,576)

Accumulated Other Comprehensive Loss - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2024
Unrecognized Net Defined Benefit Plan Costs
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive (loss) reclassification adjustment from AOCI	$ (2.2)	$ (5.7)
Benefit for income taxes	0.4	1.2
Amortization of net actuarial (losses), before tax	(2.1)	(5.7)
Accumulated Translation Adjustment
Accumulated Other Comprehensive Income (Loss) [Line Items]
Foreign currency gains (losses)	54.8	(8.9)
Foreign currency gains of net investment hedges included in accumulated other comprehensive	(20.9)	(5.4)
Foreign currency translation, tax benefit (provision) related to net investment hedges	$ 5.0	$ 1.3

Inventories - Schedule of Inventory (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Inventory Disclosure [Abstract]
Raw materials	$ 400,916	$ 465,375	$ 460,137
Work-in-process	192,986	219,462	220,164
Finished goods	486,641	556,737	565,790
Other	17,282	16,616	17,234
Inventories, gross	1,097,825	1,258,190	1,263,325
Adjustment to value inventory at cost on the LIFO method	(317,382)	(317,382)	(344,312)
Inventories	$ 780,443	$ 940,808	$ 919,013

Long-Term Debt - Schedule of Long-term Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Debt Instrument [Line Items]
Total debt - principal	$ 3,817,869	$ 3,439,835	$ 4,224,670
Less unamortized debt issuance costs and debt discount	9,819	13,069	14,176
Total debt	3,808,050	3,426,766	4,210,494
Less current portion	1,254,391	880,315	897,809
Long-term debt	2,553,659	2,546,451	3,312,685
Bank debt
Debt Instrument [Line Items]
Total debt - principal	1,398,127	1,006,243	1,843,502
3¼% Senior Notes \| Senior Notes
Debt Instrument [Line Items]
Total debt - principal	725,400
Less current portion	$ 725,400
Senior note interest rate	3.25%
Finance leases
Debt Instrument [Line Items]
Total debt - principal	$ 36,342	63,302	63,663
Bank revolving loans \| Bank debt
Debt Instrument [Line Items]
Total debt - principal	505,000	0	818,000
U.S. term loans \| Bank debt
Debt Instrument [Line Items]
Total debt - principal	850,000	950,000	950,000
Other foreign bank revolving and term loans \| Bank debt
Debt Instrument [Line Items]
Total debt - principal	43,127	56,243	75,502
Less current portion	22,300
Senior Notes \| 3¼% Senior Notes
Debt Instrument [Line Items]
Total debt - principal		717,990	688,155
Senior Notes \| 4⅛% Senior Notes
Debt Instrument [Line Items]
Total debt - principal	$ 600,000	600,000	600,000
Senior note interest rate	4.125%
Senior Notes \| 2¼% Senior Notes
Debt Instrument [Line Items]
Total debt - principal	$ 558,000	552,300	529,350
Senior note interest rate	2.25%
Senior Notes \| 1.4% Senior Secured Notes
Debt Instrument [Line Items]
Total debt - principal	$ 500,000	$ 500,000	$ 500,000
Senior note interest rate	1.40%
U.S. revolving loans \| Bank debt
Debt Instrument [Line Items]
Less current portion	$ 505,000
Finance leases
Debt Instrument [Line Items]
Less current portion	$ 1,700

Long-Term Debt - Narrative (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Debt Instrument [Line Items]
Long-term debt, current maturities	$ 1,254,391	$ 880,315	$ 897,809
Finance leases
Debt Instrument [Line Items]
Long-term debt, current maturities	1,700
Bank debt \| Other Foreign Bank Revolving and Term Loans
Debt Instrument [Line Items]
Long-term debt, current maturities	22,300
3¼% Senior Notes \| Senior Notes
Debt Instrument [Line Items]
Long-term debt, current maturities	$ 725,400

Financial Instruments - Carrying Amounts and Estimated Fair Values of Other Financial Instruments (Details) $ in Thousands	Sep. 30, 2024 USD ($)
3¼% Senior Notes \| Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior note interest rate	3.25%
Senior Notes \| 4⅛% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior note interest rate	4.125%
Senior Notes \| 2¼% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior note interest rate	2.25%
Senior Notes \| 1.4% Senior Secured Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior note interest rate	1.40%
Carrying Amount
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	$ 368,507
Carrying Amount \| 3¼% Senior Notes \| Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term senior notes	725,400
Carrying Amount \| Bank debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term senior notes	1,398,127
Carrying Amount \| Senior Notes \| 4⅛% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term senior notes	599,532
Carrying Amount \| Senior Notes \| 2¼% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term senior notes	558,000
Carrying Amount \| Senior Notes \| 1.4% Senior Secured Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term senior notes	499,916
Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	368,507
Fair Value \| 3¼% Senior Notes \| Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term senior notes	723,949
Fair Value \| Bank debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term senior notes	1,398,127
Fair Value \| Senior Notes \| 4⅛% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term senior notes	585,354
Fair Value \| Senior Notes \| 2¼% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term senior notes	524,609
Fair Value \| Senior Notes \| 1.4% Senior Secured Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term senior notes	$ 474,235

Financial Instruments - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2024	Mar. 31, 2023
2¼% Senior Notes \| Senior Notes
Derivative [Line Items]
Senior note interest rate	2.25%	2.25%
4⅛% Senior Notes \| Senior Notes
Derivative [Line Items]
Senior note interest rate	4.125%	4.125%
3¼% Senior Notes \| Senior Notes
Derivative [Line Items]
Senior note interest rate	3.25%	3.25%
1.4% Senior Secured Notes \| Senior Notes
Derivative [Line Items]
Senior note interest rate	1.40%	1.40%
USD Interest Rate Swap, Maturity Date April, 2026
Derivative [Line Items]
Derivative, notional amount			$ 300.0
Fixed interest rate			3.90%
Accumulated Translation Adjustment
Derivative [Line Items]
Foreign currency (losses) gains of net investment hedges included in accumulated other comprehensive loss	$ (20.9)	$ (5.4)

Supply Chain Finance Program (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Payables and Accruals [Abstract]
Termination notice period (at least)	30 days
Termination notice period by financial institution (at least)	10 days
Supply chain finance program, payment period (up to)	210 days
Supplier chain finance program obligation, current	$ 284.2	$ 330.2	$ 294.1

Retirement Benefits - Components of Net Periodic Benefit Cost (Credit) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Pension Benefit Cost (Credit)
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 1,990	$ 1,962	$ 6,319	$ 6,425
Interest cost	8,592	8,617	25,413	26,050
Expected return on plan assets	(10,772)	(10,211)	(32,314)	(30,587)
Amortization of prior service cost	22	29	68	82
Amortization of actuarial losses (gains)	2,232	2,845	5,937	8,729
Net periodic benefit cost (credit)	2,064	3,242	5,423	10,699
Other Postretirement Benefit Credit
Defined Benefit Plan Disclosure [Line Items]
Service cost	8	12	22	38
Interest cost	151	181	483	559
Amortization of prior service cost	(5)	(237)	(15)	(705)
Amortization of actuarial losses (gains)	(102)	(141)	(270)	(464)
Net periodic benefit cost (credit)	$ 52	$ (185)	$ 220	$ (572)

Treasury Stock (Details) - USD ($) $ / shares in Units, $ in Millions	9 Months Ended
	Sep. 30, 2024	Mar. 04, 2022
Equity, Class of Treasury Stock [Line Items]
Treasury stock (in shares)	68,317,846
2022 BOD Authorized Common Stock Repurchase
Equity, Class of Treasury Stock [Line Items]
Stock repurchase program, additional repurchase authorization		$ 300.0
Remaining authorized repurchase amount	$ 93.3
Activity Related to Restricted Stock Units Vested Under a prior Stock-based Compensation Plan
Equity, Class of Treasury Stock [Line Items]
Treasury shares issued for restricted stock units that vested during the period (in shares)	470,788
Average cost of treasury shares that were issued for restricted stock units that vested during the period (usd per share)	$ 3.19
Shares repurchased to satisfy minimum employee withholding tax requirements resulting from the vesting of such restricted stock units (in shares)	176,093
Average cost per share of treasury stock acquired (usd per share)	$ 43.92

Stock-Based Compensation (Details) $ in Millions	9 Months Ended
Stock-Based Compensation (Details) $ in Millions	Sep. 30, 2024 USD ($) plan shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of share-based compensation arrangements \| plan	1
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock units granted (in shares) \| shares	490,672
Fair value of restricted stock units granted \| $	$ 21.6

Segment Information - Reportable Business Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Segment Reporting Information [Line Items]
Net sales	$ 1,745,124	$ 1,803,101	$ 4,443,527	$ 4,648,109
Income before interest and income taxes	167,287	194,091	420,859	469,312
Adjusted EBIT	205,588	214,433	506,432	524,635
Depreciation	54,350	51,965	160,645	156,888
Dispensing and Specialty Closures
Segment Reporting Information [Line Items]
Net sales	563,669	559,081	1,664,966	1,699,109
Income before interest and income taxes	74,659	77,949	213,320	212,612
Adjusted EBIT	95,216	93,786	265,773	253,604
Depreciation	25,755	25,691	76,290	76,206
Metal Containers
Segment Reporting Information [Line Items]
Net sales	1,022,605	1,094,609	2,290,530	2,475,569
Income before interest and income taxes	89,307	110,185	187,290	231,563
Adjusted EBIT	97,065	113,519	200,532	241,659
Depreciation	19,801	18,177	57,606	54,693
Custom Containers
Segment Reporting Information [Line Items]
Net sales	158,850	149,411	488,031	473,431
Income before interest and income taxes	17,136	10,668	55,464	46,082
Adjusted EBIT	20,011	11,839	62,724	50,317
Depreciation	8,747	8,089	26,634	25,923
Corporate
Segment Reporting Information [Line Items]
Net sales	0	0	0	0
Income before interest and income taxes	(13,815)	(4,711)	(35,215)	(20,945)
Adjusted EBIT	(6,704)	(4,711)	(22,597)	(20,945)
Depreciation	$ 47	$ 8	$ 115	$ 66

Segment Information - Reconciliation of Adjusted EBIT to Income before Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Segment Reporting Information [Line Items]
Total adjusted EBIT	$ 205,588	$ 214,433	$ 506,432	$ 524,635
Less:
Rationalization charges	19,483	6,424	38,033	13,212
Income before interest and income taxes	167,287	194,091	420,859	469,312
Less interest and other debt expense	41,871	47,264	121,861	130,822
Income before income taxes	125,416	146,827	298,998	338,490
Segment Reconciling Items
Less:
Acquired intangible asset amortization expense	12,367	13,309	38,004	39,834
Other pension (income) expense for U.S. pension plans	(660)	609	(3,082)	2,277
Rationalization charges	19,483	6,424	38,033	13,212
Costs attributed to announced acquisitions	$ 7,111	$ 0	$ 12,618	$ 0

Subsequent Events (Details) employee in Thousands, € in Millions, $ in Millions	Nov. 04, 2024 EUR (€)	Oct. 15, 2024 EUR (€) employee facility	Nov. 04, 2024 USD ($)	Nov. 04, 2024 EUR (€)	Nov. 03, 2024 USD ($)	Nov. 03, 2024 EUR (€)	Oct. 31, 2024 EUR (€)	Sep. 30, 2024
1.4% Senior Secured Notes \| Senior Notes
Subsequent Event [Line Items]
Senior note interest rate								1.40%
3¼% Senior Notes \| Senior Notes
Subsequent Event [Line Items]
Senior note interest rate								3.25%
Subsequent Event \| Euro Dollar Interest Rate Swap
Subsequent Event [Line Items]
Derivative, notional amount							€ 685.0
Fixed interest rate							2.43%
Subsequent Event \| Euro Dollar Interest Rate Swap, Maturity Date October, 2026
Subsequent Event [Line Items]
Derivative, notional amount							€ 35.0
Subsequent Event \| Euro Dollar Interest Rate Swap, Maturity Date October, 2027
Subsequent Event [Line Items]
Derivative, notional amount							70.0
Subsequent Event \| Euro Dollar Interest Rate Swap, Maturity Date October, 2030
Subsequent Event [Line Items]
Derivative, notional amount							€ 580.0
Subsequent Event \| Bank Borrowings Under 2021 Credit Agreement \| Euro Term Loan
Subsequent Event [Line Items]
Debt instrument, face amount						€ 700.0
Subsequent Event \| Bank Borrowings Under 2021 Credit Agreement \| Multicurrency Revolving Loan Facility
Subsequent Event [Line Items]
Uncommitted multi-currency incremental loan, borrowing capacity \| $					$ 1,250.0
Subsequent Event \| Bank Credit Agreement, Fifth Amendment \| Euro Term Loan
Subsequent Event [Line Items]
Debt instrument, face amount				€ 900.0
Long-term debt, maturity, year one				9.0
Long-term debt, maturity, year two				45.0
Long-term debt, maturity, year three				90.0
Long-term debt, maturity, year four				90.0
Long-term debt, maturity, year five				90.0
Long-term debt, maturity, after year five				€ 576.0
Subsequent Event \| Bank Credit Agreement, Fifth Amendment \| Multicurrency Revolving Loan Facility
Subsequent Event [Line Items]
Uncommitted multi-currency incremental loan, borrowing capacity \| $			$ 1,500.0
Subsequent Event \| Bank Credit Agreement, Fifth Amendment \| US Term Loans
Subsequent Event [Line Items]
Long-term debt, maturity, year one \| $			8.5
Long-term debt, maturity, year two \| $			42.5
Long-term debt, maturity, year three \| $			85.0
Long-term debt, maturity, year four \| $			85.0
Long-term debt, maturity, year five \| $			85.0
Long-term debt, maturity, after year five \| $			$ 544.0
Subsequent Event \| Bank Credit Agreement, Fifth Amendment, Portion Used to Repay Revolving Loans \| Euro Term Loan
Subsequent Event [Line Items]
Proceeds from Issuance of Debt	€ 200.0
Weener Plastics Holding B.V. \| Subsequent Event
Subsequent Event [Line Items]
Number of manufacturing facilities \| facility		19
Entity number of employees \| employee		4
Weener Plastics Holding B.V. \| Subsequent Event
Subsequent Event [Line Items]
Payments to acquire businesses, net of cash acquired		€ 844.2
Weener Plastics Holding B.V. \| Subsequent Event \| Incremental Term Loan
Subsequent Event [Line Items]
Business combination, liabilities incurred		€ 700.0